{"1.22":{"start":"1.224","dur":"3.172","text":"FEMALE SPEAKER: Dr. David Solit."},"4.40":{"start":"4.396","dur":"1.814","text":"I have to start with\na personal note."},"6.21":{"start":"6.21","dur":"1.3","text":"He&#39;s part of my family."},"7.51":{"start":"7.51","dur":"4.64","text":"And so I&#39;ve always been\nexcited about David"},"12.15":{"start":"12.15","dur":"2.67","text":"and who he is as a person,\nand I&#39;m excited about his work"},"14.82":{"start":"14.82","dur":"1.87","text":"as well."},"16.69":{"start":"16.69","dur":"1.81","text":"He&#39;s my nephew."},"18.50":{"start":"18.5","dur":"2.26","text":"But more importantly\nthan that, he&#39;s"},"20.76":{"start":"20.76","dur":"4.11","text":"the director at the Kravis\nCenter for Molecular Oncology"},"24.87":{"start":"24.87","dur":"5.19","text":"at the Memorial Sloan Kettering\nCancer Center in New York City."},"30.06":{"start":"30.06","dur":"2.94","text":"He&#39;s both a researcher\nand clinician,"},"33.00":{"start":"33","dur":"3.16","text":"and works on all\nareas of cancer."},"36.16":{"start":"36.16","dur":"4.08","text":"And today he&#39;s going to talk\nabout an aspect of his research"},"40.24":{"start":"40.24","dur":"2.19","text":"that I find fascinating\nwhen I understand it."},"42.43":{"start":"42.43","dur":"4.39","text":"And so thank you so much David,\nfor coming and talking to us."},"46.82":{"start":"46.82","dur":"4.87","text":"DAVID B. SOLIT: Thanks for\nthe invitation to present."},"51.69":{"start":"51.69","dur":"4.417","text":"I am out here this weekend\nriding in a cancer fundraiser"},"56.11":{"start":"56.107","dur":"1.083","text":"called Cycle for Survival."},"57.19":{"start":"57.19","dur":"4.87","text":"So since I was in town, I\nguess I had the opportunity"},"62.06":{"start":"62.06","dur":"2.827","text":"to create this\nGoogle YouTube stream"},"64.89":{"start":"64.887","dur":"1.833","text":"and speak to you guys\ntoday about what we&#39;ve"},"66.72":{"start":"66.72","dur":"2.21","text":"been doing at Sloan Kettering."},"68.93":{"start":"68.93","dur":"3.44","text":"So really what I want to\ntalk to you about today"},"72.37":{"start":"72.37","dur":"3.83","text":"is how we&#39;re trying to use\na big data computational"},"76.20":{"start":"76.2","dur":"2.63","text":"approach to identify\nnew drug targets,"},"78.83":{"start":"78.83","dur":"1.84","text":"and how we&#39;re actually\nstudying what we"},"80.67":{"start":"80.67","dur":"1.48","text":"call extraordinary responders."},"82.15":{"start":"82.15","dur":"3.46","text":"These are patients who\nreally beat the odds."},"85.61":{"start":"85.61","dur":"3.3","text":"These are people who have a\ncancer that most patients die"},"88.91":{"start":"88.91","dur":"2.33","text":"of, and oftentimes very quickly."},"91.24":{"start":"91.24","dur":"1.62","text":"But these are those\nrare individuals"},"92.86":{"start":"92.86","dur":"2.41","text":"who overcame those odds and\nare alive many years later."},"95.27":{"start":"95.27","dur":"3.87","text":"And what we try to do is analyze\ntumors from those patients"},"99.14":{"start":"99.14","dur":"1.81","text":"so that we can learn\nlessons from that"},"100.95":{"start":"100.95","dur":"2.08","text":"and hopefully identify\nnew drug targets"},"103.03":{"start":"103.03","dur":"3.74","text":"that we can apply in the\nbroader population of patients."},"106.77":{"start":"106.77","dur":"3.29","text":"So I&#39;ve been at Sloan\nKettering now it&#39;s 18 years."},"110.06":{"start":"110.06","dur":"1.76","text":"And I run both the research lab."},"111.82":{"start":"111.82","dur":"2.81","text":"I also see patients as\na medical oncologist."},"114.63":{"start":"114.63","dur":"3.33","text":"And really what the focus\nof my lab&#39;s efforts is"},"117.96":{"start":"117.96","dur":"2.58","text":"is to really try to\nidentify these drug targets."},"120.54":{"start":"120.54","dur":"3.8","text":"And so we try to accelerate\nthis target discovery."},"124.34":{"start":"124.34","dur":"2.74","text":"And it&#39;s a pretty simple\nparadigm that we follow."},"127.08":{"start":"127.08","dur":"2.41","text":"It&#39;s really up here on\nthis first slide here."},"129.49":{"start":"129.49","dur":"1.042","text":"We try to define targets."},"130.53":{"start":"130.532","dur":"1.832","text":"And I&#39;m going to spend\na few minutes talking"},"132.36":{"start":"132.364","dur":"2.476","text":"about what these targets\nare and how we find them."},"134.84":{"start":"134.84","dur":"2.315","text":"We then, in the\nlaboratory, try to identify"},"137.16":{"start":"137.155","dur":"1.965","text":"a drug that selectively\nwill inhibit"},"139.12":{"start":"139.12","dur":"3.41","text":"that altered target that&#39;s\nmaking the cancer cell grow"},"142.53":{"start":"142.53","dur":"2.4","text":"or something downstream\nfrom that drug target"},"144.93":{"start":"144.93","dur":"1.67","text":"that&#39;ll kill the cancer cell."},"146.60":{"start":"146.6","dur":"1.5","text":"And then what is a\nmajor challenge--"},"148.10":{"start":"148.1","dur":"2.24","text":"and I&#39;ll talk to you about\nthat for the second part"},"150.34":{"start":"150.34","dur":"2.3","text":"of the talk-- is\nhow do we identify"},"152.64":{"start":"152.64","dur":"3.41","text":"the individual patients who\nhave an alteration in their drug"},"156.05":{"start":"156.05","dur":"2.79","text":"target so that we can give\nthem a particular drug?"},"158.84":{"start":"158.84","dur":"1.98","text":"And that&#39;s really\nwhat we try to do."},"160.82":{"start":"160.82","dur":"1.51","text":"So what are these targets?"},"162.33":{"start":"162.33","dur":"2.88","text":"There&#39;s really two main ways\nto identify these targets."},"165.21":{"start":"165.21","dur":"2.5","text":"One&#39;s called a genotype\nto phenotype approach."},"167.71":{"start":"167.71","dur":"2.895","text":"And then I&#39;ll mention to you the\nopposite, which is a phenotype"},"170.61":{"start":"170.605","dur":"0.875","text":"to genotype approach."},"171.48":{"start":"171.48","dur":"2.84","text":"So the genotype to phenotype\napproach-- or G to P--"},"174.32":{"start":"174.32","dur":"3.36","text":"is where we take a large\ngroup of tumor samples"},"177.68":{"start":"177.68","dur":"3.36","text":"and then we retrospectively do\nmolecular profiling on them."},"181.04":{"start":"181.04","dur":"2.62","text":"And this is usually what&#39;s\ncalled next-gen sequencing"},"183.66":{"start":"183.66","dur":"1.28","text":"at this point."},"184.94":{"start":"184.94","dur":"1.72","text":"There are three\nbillion base pairs"},"186.66":{"start":"186.66","dur":"1.97","text":"of DNA within the human genome."},"188.63":{"start":"188.63","dur":"1.61","text":"And what we try\nto do is sequence"},"190.24":{"start":"190.24","dur":"2.72","text":"that genome in these\nindividual tumors"},"192.96":{"start":"192.96","dur":"1.71","text":"and then use a\nstatistical approach"},"194.67":{"start":"194.67","dur":"3.64","text":"to find things that are commonly\naltered in multiple patients"},"198.31":{"start":"198.31","dur":"1.02","text":"with the same cancer."},"199.33":{"start":"199.33","dur":"2.59","text":"So if you see the same\nmutation again and again"},"201.92":{"start":"201.92","dur":"1.82","text":"in a particular\ncancer type, that"},"203.74":{"start":"203.74","dur":"3.01","text":"gives you a statistical clue\nthat that mutation maybe"},"206.75":{"start":"206.75","dur":"2.43","text":"is important for the\ngrowth of that cancer."},"209.18":{"start":"209.18","dur":"3.85","text":"And so this was really the paper\nthat really changed my career."},"213.03":{"start":"213.03","dur":"2.804","text":"I was what was called a\npostdoctoral fellow working"},"215.83":{"start":"215.834","dur":"1.416","text":"in the laboratory\nof someone else."},"217.25":{"start":"217.25","dur":"2.24","text":"I hadn&#39;t gotten\nmy own laboratory"},"219.49":{"start":"219.49","dur":"2.13","text":"when this paper came\nout in a journal called"},"221.62":{"start":"221.62","dur":"2.62","text":"&quot;Nature,&quot; which is\none of the big biology"},"224.24":{"start":"224.24","dur":"1.36","text":"journals in the field."},"225.60":{"start":"225.6","dur":"3.3","text":"And it was a very simple\nexperiment that they did."},"228.90":{"start":"228.9","dur":"3.42","text":"What they did is they took\n1,000 cancer samples--"},"232.32":{"start":"232.32","dur":"3.21","text":"some tumors, some cell\nlines that were tumors"},"235.53":{"start":"235.53","dur":"2.54","text":"that they now had\ngrowing on plastic--"},"238.07":{"start":"238.07","dur":"2.46","text":"and they sequenced a\ncommon pathway that&#39;s"},"240.53":{"start":"240.53","dur":"2.522","text":"activated in cancer called\nthe MAP kinase pathway."},"243.05":{"start":"243.052","dur":"1.458","text":"And then what they\nwere looking for"},"244.51":{"start":"244.51","dur":"5.63","text":"was genes that hadn&#39;t been known\nto be mutated that were mutated"},"250.14":{"start":"250.14","dur":"1.34","text":"in these tumors commonly."},"251.48":{"start":"251.48","dur":"2.09","text":"And so when they\nsequenced that pathway,"},"253.57":{"start":"253.57","dur":"1.82","text":"they found this\ngene called BRAF."},"255.39":{"start":"255.39","dur":"2.819","text":"And this was interesting\nbecause at the time,"},"258.21":{"start":"258.209","dur":"1.37","text":"nobody had studied BRAF."},"259.58":{"start":"259.579","dur":"2.51","text":"There&#39;s actually three\ndifferent types of RAF proteins."},"262.09":{"start":"262.089","dur":"2.251","text":"There&#39;s ARAF, there&#39;s\nBRAF, there&#39;s CRAF."},"264.34":{"start":"264.34","dur":"2.07","text":"CRAF is also called\nRAF1, and it&#39;s the one"},"266.41":{"start":"266.41","dur":"2.292","text":"that everyone had been\nbiologically focusing on."},"268.70":{"start":"268.702","dur":"2.458","text":"And it turned out that people\nwere really missing the boat."},"271.16":{"start":"271.16","dur":"3.77","text":"And this non-biased approach,\nby just sequencing 1,000 tumors,"},"274.93":{"start":"274.93","dur":"2.78","text":"identified that BRAF mutations\nwere found in about 80"},"277.71":{"start":"277.71","dur":"3.29","text":"of those, so in about\n8% of all those tumors."},"281.00":{"start":"281","dur":"1.95","text":"And that was about\n50% of melanomas,"},"282.95":{"start":"282.95","dur":"3.11","text":"but also scattered\nthroughout other tumor types."},"286.06":{"start":"286.06","dur":"2.22","text":"What was notable about\nthese BRAF mutations"},"288.28":{"start":"288.28","dur":"4.9","text":"is that about 95% of them\nwere the exact same change"},"293.18":{"start":"293.18","dur":"0.63","text":"in the DNA."},"293.81":{"start":"293.81","dur":"5.39","text":"So it was a substitution\nof one amino nucleotide"},"299.20":{"start":"299.2","dur":"1.85","text":"for another nucleotide,\nwhich causes"},"301.05":{"start":"301.05","dur":"4.68","text":"a single base pair amino\nacid change in this protein."},"305.73":{"start":"305.73","dur":"2.85","text":"And when you do that, you\nactually activate that protein"},"308.58":{"start":"308.58","dur":"0.7","text":"constitutively."},"309.28":{"start":"309.28","dur":"2.27","text":"So that&#39;s why these\npeople get cancer."},"311.55":{"start":"311.55","dur":"3.34","text":"They have an abnormal protein\nthat&#39;s always turned on."},"314.89":{"start":"314.89","dur":"2.45","text":"And when you have a\nsituation like that,"},"317.34":{"start":"317.34","dur":"3.92","text":"if you can develop an inhibitor\nof that activated enzyme,"},"321.26":{"start":"321.26","dur":"1.92","text":"you oftentimes have\na new cancer drug."},"323.18":{"start":"323.18","dur":"3.05","text":"And that&#39;s what we tested\nin the lab after that."},"326.23":{"start":"326.23","dur":"3.08","text":"So what we did is we took a\npanel of cancer cell lines."},"329.31":{"start":"329.31","dur":"3.84","text":"We looked to see which ones had\nBRAF mutations, which ones had"},"333.15":{"start":"333.15","dur":"2.54","text":"a mutation upstream called\nRAS that had already"},"335.69":{"start":"335.69","dur":"2.47","text":"been discovered a\nfew years prior,"},"338.16":{"start":"338.16","dur":"1.45","text":"and then which\nones had activation"},"339.61":{"start":"339.61","dur":"2.14","text":"of this, what&#39;s called\nMAP kinase pathway,"},"341.75":{"start":"341.75","dur":"1.91","text":"but due to upstream activation."},"343.66":{"start":"343.66","dur":"1.79","text":"And what we found\nin the laboratory"},"345.45":{"start":"345.45","dur":"2.73","text":"was that these tumors\nthat had BRAF mutations"},"348.18":{"start":"348.18","dur":"2.03","text":"were selectively\ndependant upon BRAF."},"350.21":{"start":"350.21","dur":"3.05","text":"Because if you have a mutation,\nand the cancer cell is not"},"353.26":{"start":"353.26","dur":"2.72","text":"dependant upon that mutation,\nthen developing a drug"},"355.98":{"start":"355.98","dur":"1.98","text":"that targets that\nmutation&#39;s probably not"},"357.96":{"start":"357.96","dur":"3.237","text":"going to have too much\nof a dramatic effect."},"361.20":{"start":"361.197","dur":"1.833","text":"If you actually look\nat the chronology here,"},"363.03":{"start":"363.03","dur":"2.8","text":"this experiment\nwas done in 2002."},"365.83":{"start":"365.83","dur":"2.92","text":"We did this biologic\nexperiment in 2006."},"368.75":{"start":"368.75","dur":"2.81","text":"And then it took\nabout til 2010 til"},"371.56":{"start":"371.56","dur":"2.86","text":"we had a good drug that we\ncould actually test in patients."},"374.42":{"start":"374.42","dur":"2.59","text":"And this is just some early\ndata from the phase one trial."},"377.01":{"start":"377.01","dur":"3.56","text":"That&#39;s the first in human study\nof a drug that selectively"},"380.57":{"start":"380.57","dur":"0.907","text":"inhibits RAF."},"381.48":{"start":"381.477","dur":"2.083","text":"And this is a patient with\nvery advanced melanoma."},"383.56":{"start":"383.56","dur":"3.79","text":"All of these dark dots here\non this PET scan are cancer."},"387.35":{"start":"387.35","dur":"1.93","text":"And you can see 15\ndays later, after being"},"389.28":{"start":"389.28","dur":"2.33","text":"on this selective\ninhibitor of BRAF,"},"391.61":{"start":"391.61","dur":"3.19","text":"this patient&#39;s had a complete\nresponse on our PET scan."},"394.80":{"start":"394.8","dur":"2.26","text":"And this is a CAT scan\nshowing regression"},"397.06":{"start":"397.06","dur":"1.68","text":"of those tumors in\nthis patient&#39;s lung."},"398.74":{"start":"398.74","dur":"2.96","text":"And ultimately in\na randomized study,"},"401.70":{"start":"401.7","dur":"1.707","text":"we were able to\nshow that this drug,"},"403.41":{"start":"403.407","dur":"1.833","text":"if you give it to\npatients with melanoma who"},"405.24":{"start":"405.24","dur":"3.8","text":"have this BRAF mutation, that\nthose patients live longer."},"409.04":{"start":"409.04","dur":"2.15","text":"And actually we were able\nto show in the laboratory"},"411.19":{"start":"411.19","dur":"1.88","text":"that if you give this\nsame drug to cells"},"413.07":{"start":"413.07","dur":"2.89","text":"that lack the BRAF mutation,\nthose cells actually"},"415.96":{"start":"415.96","dur":"0.77","text":"grow faster."},"416.73":{"start":"416.73","dur":"1.99","text":"So it really becomes\ncritical that"},"418.72":{"start":"418.72","dur":"2.92","text":"for each individual patient,\nbefore we treat them,"},"421.64":{"start":"421.64","dur":"2.09","text":"we know whether they\nhave the BRAF mutation"},"423.73":{"start":"423.73","dur":"1.97","text":"or whether they don&#39;t\nhave the BRAF mutation."},"425.70":{"start":"425.7","dur":"2.05","text":"Because if we give them\nthe BRAF inhibitor,"},"427.75":{"start":"427.75","dur":"2.954","text":"they&#39;re likely to benefit if\nthey have a BRAF mutation."},"430.70":{"start":"430.704","dur":"1.416","text":"If we give them\nthe BRAF inhibitor"},"432.12":{"start":"432.12","dur":"2.03","text":"and they&#39;re BRAF\nwild type tumor,"},"434.15":{"start":"434.15","dur":"1.56","text":"their tumor may\nactually grow faster"},"435.71":{"start":"435.71","dur":"1.59","text":"and they may die quicker."},"437.30":{"start":"437.3","dur":"3.94","text":"So really what the challenge has\nbecome somewhat in our cancer"},"441.24":{"start":"441.24","dur":"2.24","text":"population is how\ndo we figure out"},"443.48":{"start":"443.48","dur":"2.574","text":"who&#39;s got what mutations\nwithin their tumor?"},"446.05":{"start":"446.054","dur":"1.416","text":"Because again,\nthese mutations can"},"447.47":{"start":"447.47","dur":"2.72","text":"be scattered over this\nentire human genome, which"},"450.19":{"start":"450.19","dur":"4.62","text":"makes up about three billion\ndifferent base pairs."},"454.81":{"start":"454.81","dur":"3.71","text":"So that&#39;s one way to\napproach this problem."},"458.52":{"start":"458.52","dur":"2.59","text":"That way is really a\nstatistical approach."},"461.11":{"start":"461.11","dur":"1","text":"It takes large numbers."},"462.11":{"start":"462.11","dur":"1.19","text":"It takes a large consortium."},"463.30":{"start":"463.3","dur":"2.64","text":"And there&#39;s an effort called\nthe Tumor Cancer Genome"},"465.94":{"start":"465.94","dur":"2.98","text":"Atlas that&#39;s trying to do\nthat across the country."},"468.92":{"start":"468.92","dur":"1.94","text":"And that&#39;s one way to do it."},"470.86":{"start":"470.86","dur":"2.19","text":"And we actually came up\nwith the opposite idea."},"473.05":{"start":"473.05","dur":"4.3","text":"Can we actually take patients\nwho were on cancer drugs"},"477.35":{"start":"477.35","dur":"3.5","text":"and they responded incredibly\nwell to those cancer drugs--"},"480.85":{"start":"480.85","dur":"3.99","text":"most patients didn&#39;t, or maybe\nnobody else didn&#39;t-- and can we"},"484.84":{"start":"484.84","dur":"2.69","text":"find out what was the mutation\nthat made them respond?"},"487.53":{"start":"487.53","dur":"1.516","text":"Because if we could\nfigure that out,"},"489.05":{"start":"489.046","dur":"1.874","text":"we already have a good\ndrug because it worked"},"490.92":{"start":"490.92","dur":"1.47","text":"in that individual already."},"492.39":{"start":"492.39","dur":"2.59","text":"And if we could just find\nother patients just like them,"},"494.98":{"start":"494.98","dur":"2.18","text":"we have a drug ready\nfor those individuals."},"497.16":{"start":"497.16","dur":"1.81","text":"So could we expand\nout the number"},"498.97":{"start":"498.97","dur":"1.57","text":"of patients who would benefit?"},"500.54":{"start":"500.54","dur":"2.55","text":"And the real inspiration\nfor this work"},"503.09":{"start":"503.09","dur":"2.83","text":"was this clinical trial that\nwe ran in Sloan Kettering"},"505.92":{"start":"505.92","dur":"0.77","text":"a few years ago."},"506.69":{"start":"506.69","dur":"3.13","text":"So this was a trial\nwe ran back in 2008."},"509.82":{"start":"509.82","dur":"2.58","text":"We did this trial in\npatients with bladder cancer."},"512.40":{"start":"512.4","dur":"3.07","text":"And like every other\nbladder cancer trial"},"515.47":{"start":"515.47","dur":"2.62","text":"we&#39;ve done over the\npast 20 to 30 years,"},"518.09":{"start":"518.09","dur":"1.24","text":"this was a negative study."},"519.33":{"start":"519.33","dur":"3.16","text":"So we enrolled 45 patients\non to this clinical trial."},"522.49":{"start":"522.49","dur":"2.89","text":"Only two of those\npatients responded."},"525.38":{"start":"525.38","dur":"3.86","text":"And based upon that result,\nstatistically one would say OK,"},"529.24":{"start":"529.24","dur":"1.96","text":"this drug which we\nwere testing here"},"531.20":{"start":"531.2","dur":"3.7","text":"called Everolimus-- it&#39;s made\nby a company called Novartis--"},"534.90":{"start":"534.9","dur":"2.72","text":"that this drug doesn&#39;t work in\npatients with bladder cancer."},"537.62":{"start":"537.62","dur":"4","text":"So let&#39;s maybe move\non to the next idea."},"541.62":{"start":"541.62","dur":"2.71","text":"But despite the fact that\nin the entire population"},"544.33":{"start":"544.33","dur":"2.04","text":"it wasn&#39;t impressive,\nthis patient"},"546.37":{"start":"546.37","dur":"2.17","text":"here-- and I&#39;m showing\nher CAT scans-- really"},"548.54":{"start":"548.54","dur":"0.9","text":"jumped out at us."},"549.44":{"start":"549.44","dur":"2.65","text":"And so just to give you\nher history briefly,"},"552.09":{"start":"552.09","dur":"2.8","text":"her history actually\nbegins off the slide here."},"554.89":{"start":"554.89","dur":"2.93","text":"In the summer of\n2009, she presented"},"557.82":{"start":"557.82","dur":"1.68","text":"with a bladder cancer\nthat had already"},"559.50":{"start":"559.5","dur":"1.34","text":"spread to her lymph nodes."},"560.84":{"start":"560.84","dur":"2.499","text":"So it was already what\nwe call metastatic."},"563.34":{"start":"563.339","dur":"2.291","text":"And what we try to do in\nthese patients is we give them"},"565.63":{"start":"565.63","dur":"2.95","text":"chemotherapy, we try to\nshrink the tumor down,"},"568.58":{"start":"568.58","dur":"1.78","text":"we try to cut\neverything out, and then"},"570.36":{"start":"570.36","dur":"3.46","text":"in a percentage of those\npatients we cure the cancer."},"573.82":{"start":"573.82","dur":"3.13","text":"But unfortunately,\nby the fall of 2009,"},"576.95":{"start":"576.95","dur":"3.04","text":"her cancer had come back, it had\nspread back to the lymph nodes."},"579.99":{"start":"579.99","dur":"3.15","text":"And you can see here in January\n2010, she had this CAT scan."},"583.14":{"start":"583.14","dur":"4.6","text":"And really this area here that\nthe red arrows are pointing at,"},"587.74":{"start":"587.74","dur":"1.25","text":"that&#39;s her tumor."},"588.99":{"start":"588.99","dur":"1.95","text":"And that spread out\nthrough her abdomen."},"590.94":{"start":"590.94","dur":"3.44","text":"And actually in this situation,\na patient with bladder cancer"},"594.38":{"start":"594.38","dur":"2.77","text":"who&#39;s had a prior\nline of chemotherapy,"},"597.15":{"start":"597.15","dur":"1.181","text":"we have no standard of care."},"598.33":{"start":"598.331","dur":"1.749","text":"And the average survival\nof these patients"},"600.08":{"start":"600.08","dur":"1.18","text":"is only nine months."},"601.26":{"start":"601.26","dur":"1.93","text":"And so we really\nencourage these patients"},"603.19":{"start":"603.19","dur":"1.48","text":"to go on clinical trials."},"604.67":{"start":"604.67","dur":"1.83","text":"And for no particular\nreason other than it"},"606.50":{"start":"606.5","dur":"2.84","text":"was an open clinical trial at\nSloan Kettering at the time,"},"609.34":{"start":"609.34","dur":"2.68","text":"this woman enrolled on\nthe Everolimus study."},"612.02":{"start":"612.02","dur":"2.93","text":"And despite the fact that this\ndrug really didn&#39;t work well"},"614.95":{"start":"614.95","dur":"3.085","text":"in anybody else,\nby April 2010 she"},"618.04":{"start":"618.035","dur":"3.005","text":"had achieved a near\ncomplete response."},"621.04":{"start":"621.04","dur":"1.91","text":"By July 2010, a\ncomplete response."},"622.95":{"start":"622.95","dur":"2.64","text":"What I mean by that is that\nall the tumors had completely"},"625.59":{"start":"625.59","dur":"1.06","text":"resolved."},"626.65":{"start":"626.65","dur":"3.83","text":"If you look at July 2011,\nstill in a complete response."},"630.48":{"start":"630.48","dur":"1.66","text":"&#39;12, &#39;13, &#39;14."},"632.14":{"start":"632.14","dur":"3.31","text":"She was actually just back in\nour clinic a few weeks ago."},"635.45":{"start":"635.45","dur":"2.97","text":"And she&#39;s now at her\nfive year anniversary"},"638.42":{"start":"638.42","dur":"4.38","text":"being on this compound without\nany evidence of disease,"},"642.80":{"start":"642.8","dur":"1.64","text":"despite the fact\nthat this again,"},"644.44":{"start":"644.44","dur":"3.83","text":"in the overall population,\nwas a negative study."},"648.27":{"start":"648.27","dur":"2.06","text":"In fact, every other\npatient on this study"},"650.33":{"start":"650.33","dur":"1.09","text":"has died of their disease."},"651.42":{"start":"651.42","dur":"1.64","text":"She&#39;s the only one who&#39;s alive."},"653.06":{"start":"653.06","dur":"3.06","text":"And not only is she alive, her\ncancer&#39;s completely gone away."},"656.12":{"start":"656.12","dur":"2.35","text":"So again, what makes her unique?"},"658.47":{"start":"658.47","dur":"4.14","text":"So at the time, back in\n2008, 2009, the technology"},"662.61":{"start":"662.61","dur":"3.03","text":"that we had available really\nallowed us to look at one gene"},"665.64":{"start":"665.64","dur":"1.042","text":"at a time for mutations."},"666.68":{"start":"666.682","dur":"1.208","text":"And that was pretty limiting."},"667.89":{"start":"667.89","dur":"2.85","text":"We could have a hypothesis\nbased upon the biology"},"670.74":{"start":"670.74","dur":"2.9","text":"around Everolimus that\nmaybe this gene or that gene"},"673.64":{"start":"673.64","dur":"1.95","text":"was important for this response."},"675.59":{"start":"675.59","dur":"1.95","text":"So we did that type of approach."},"677.54":{"start":"677.54","dur":"2.93","text":"We looked at a few genes\nand a candidate approach."},"680.47":{"start":"680.47","dur":"3.76","text":"Couldn&#39;t find what really was\nunique about this patient."},"684.23":{"start":"684.23","dur":"2.87","text":"But what happened along the way\nis that technology improved."},"687.10":{"start":"687.1","dur":"4.31","text":"And this was both what we\ncall sequencing technology"},"691.41":{"start":"691.41","dur":"2.15","text":"and then also just the\ncomputational power,"},"693.56":{"start":"693.56","dur":"4.02","text":"our ability to analyze this\ndata expanded to the point"},"697.58":{"start":"697.58","dur":"1.7","text":"where we could now\ndo whole genomes."},"699.28":{"start":"699.28","dur":"2.88","text":"And so actually, the first\nwhole genome sequence"},"702.16":{"start":"702.16","dur":"2.66","text":"of a normal cell\nwas not completed"},"704.82":{"start":"704.82","dur":"1.92","text":"until about the year 2000."},"706.74":{"start":"706.74","dur":"4.73","text":"The first cancer genomes were\nonly about five years ago."},"711.47":{"start":"711.47","dur":"2.07","text":"And those first\ncancer genomes were"},"713.54":{"start":"713.54","dur":"3.51","text":"costing on an average hundreds\nof millions of dollars"},"717.05":{"start":"717.05","dur":"2.33","text":"to complete in their entirety."},"719.38":{"start":"719.38","dur":"3.07","text":"The technology eventually\nprogressed to the point where,"},"722.45":{"start":"722.45","dur":"2.64","text":"for just a small amount\nof money at the time,"},"725.09":{"start":"725.09","dur":"2.01","text":"for this paired\ngenome for sequencing"},"727.10":{"start":"727.1","dur":"3.36","text":"both their tumor and their\nnormal cost about $20,000."},"730.46":{"start":"730.46","dur":"2.38","text":"That&#39;s already down\nto about $2,000"},"732.84":{"start":"732.84","dur":"2.04","text":"today, just a few years later."},"734.88":{"start":"734.88","dur":"2.83","text":"But again, by being able to\nsequence her whole genome"},"737.71":{"start":"737.71","dur":"2.3","text":"and being able to\nanalyze all that data,"},"740.01":{"start":"740.01","dur":"2.66","text":"we&#39;re able to figure out every\nsingle place in her tumor"},"742.67":{"start":"742.67","dur":"2.046","text":"genome where there&#39;s\na mutation and it&#39;s"},"744.72":{"start":"744.716","dur":"1.374","text":"different than\nher normal genome."},"746.09":{"start":"746.09","dur":"2.55","text":"And if you do that\nanalysis, you come up"},"748.64":{"start":"748.64","dur":"3.78","text":"with 17,000 mutations\nthat are in her tumor that"},"752.42":{"start":"752.42","dur":"0.99","text":"are not in her normal."},"753.41":{"start":"753.41","dur":"1.791","text":"And you say well, how\nare you going to sort"},"755.20":{"start":"755.201","dur":"2.409","text":"through 17,000 data points?"},"757.61":{"start":"757.61","dur":"2.12","text":"But it&#39;s a real\ntestament to how much"},"759.73":{"start":"759.73","dur":"2.29","text":"we&#39;ve learned about the\nbiology of these genes"},"762.02":{"start":"762.02","dur":"2.67","text":"over the past several\ndecades that we&#39;re"},"764.69":{"start":"764.69","dur":"3","text":"able to very quickly\nbioinformatically map"},"767.69":{"start":"767.69","dur":"2.73","text":"every single one of\nthese 17,000 mutations"},"770.42":{"start":"770.42","dur":"1.83","text":"to what we call the\nreference genome."},"772.25":{"start":"772.25","dur":"2.68","text":"We can ask, which\nof these mutations"},"774.93":{"start":"774.93","dur":"3.08","text":"are present in a coding\nregion of a gene?"},"778.01":{"start":"778.01","dur":"1.94","text":"Which of these\nmutations would be"},"779.95":{"start":"779.95","dur":"3.21","text":"predicted, based\nupon an algorithm,"},"783.16":{"start":"783.16","dur":"1.86","text":"to change the protein function?"},"785.02":{"start":"785.02","dur":"3.46","text":"And which of these genes that\nchange a protein function when"},"788.48":{"start":"788.48","dur":"2.9","text":"they have a mutation would\nbe predicted to be associated"},"791.38":{"start":"791.38","dur":"1.14","text":"with Everolimus response?"},"792.52":{"start":"792.52","dur":"1.71","text":"And when you do\nthat, you can take"},"794.23":{"start":"794.23","dur":"3.38","text":"all 17,000 of these mutations\nand actually boil it down"},"797.61":{"start":"797.61","dur":"4.61","text":"to just two-- one called TSE1\nand the other called NF2."},"802.22":{"start":"802.22","dur":"1.98","text":"And the reason these\nwere so interesting"},"804.20":{"start":"804.2","dur":"4.02","text":"is that when you mutated\nboth TSE1 and TSE2,"},"808.22":{"start":"808.22","dur":"2.94","text":"you activated a\nprotein TORC-1, which"},"811.16":{"start":"811.16","dur":"1.61","text":"is the direct target\nof Everolimus."},"812.77":{"start":"812.77","dur":"2.26","text":"So if you look at this\npatient in retrospect,"},"815.03":{"start":"815.03","dur":"3.12","text":"she was the perfect\npatient to get this drug."},"818.15":{"start":"818.15","dur":"2.616","text":"We simply didn&#39;t know it\ngoing into the clinical trial,"},"820.77":{"start":"820.766","dur":"1.374","text":"because we didn&#39;t\nknow what genes"},"822.14":{"start":"822.14","dur":"2.27","text":"were mutated in her tumor."},"824.41":{"start":"824.41","dur":"2.59","text":"Actually, at about the\ntime-- I&#39;ll just go back--"},"827.00":{"start":"827","dur":"2.242","text":"that we were getting\nthese results back,"},"829.24":{"start":"829.242","dur":"1.458","text":"there was actually\na clinical trial"},"830.70":{"start":"830.7","dur":"2.92","text":"published that this same\ndrug Everolimus works"},"833.62":{"start":"833.62","dur":"2.93","text":"in patients who have a condition\ncalled tuberous sclerosis."},"836.55":{"start":"836.55","dur":"2.94","text":"This is an inherited disease\nwhere patients get cancer"},"839.49":{"start":"839.49","dur":"2.63","text":"at a very young age due\nto germ line mutations"},"842.12":{"start":"842.12","dur":"1.74","text":"in the same gene, TSE1."},"843.86":{"start":"843.86","dur":"2.44","text":"And so these are people who\nare born with already one"},"846.30":{"start":"846.3","dur":"1.82","text":"defective copy of this gene."},"848.12":{"start":"848.12","dur":"2.88","text":"If they lose the other\ncopy in a normal cell,"},"851.00":{"start":"851","dur":"0.93","text":"they then get tumors."},"851.93":{"start":"851.93","dur":"2.57","text":"And because normally you have\nto lose both copies of a gene,"},"854.50":{"start":"854.5","dur":"2.326","text":"if it&#39;s a tumor\nsuppressor, to get a tumor,"},"856.83":{"start":"856.826","dur":"2.124","text":"these people are very\nsusceptible to getting cancer"},"858.95":{"start":"858.95","dur":"2.02","text":"and they get cancer\nat a very young age."},"860.97":{"start":"860.97","dur":"3.47","text":"So we&#39;ve now taken this\nextraordinary responder"},"864.44":{"start":"864.44","dur":"2.25","text":"paradigm and we&#39;ve\napplied it to other cases."},"866.69":{"start":"866.69","dur":"3.41","text":"And I just want to mention\none other quickly here today."},"870.10":{"start":"870.1","dur":"4.74","text":"This is a second patient who\nwas a young woman in her 40s."},"874.84":{"start":"874.84","dur":"3.46","text":"She presented with a\nmass in her abdomen."},"878.30":{"start":"878.3","dur":"2.97","text":"It was a localized tumor, so\nthe surgeons opened her up."},"881.27":{"start":"881.27","dur":"1.645","text":"They went ahead and\ncut out this tumor."},"882.92":{"start":"882.915","dur":"2.125","text":"And if you look at this\ntumor under the microscope,"},"885.04":{"start":"885.04","dur":"2.04","text":"this patient has what&#39;s\ncalled a small cell"},"887.08":{"start":"887.08","dur":"1.77","text":"cancer of the urothelial tract."},"888.85":{"start":"888.85","dur":"3.79","text":"And this type of tumor has a\nparticularly grim prognosis."},"892.64":{"start":"892.64","dur":"2.73","text":"So if you look at our series\nof this type of cancer"},"895.37":{"start":"895.37","dur":"1.98","text":"at Sloan Kettering\nover the past 10 years,"},"897.35":{"start":"897.35","dur":"2.49","text":"essentially all patients\nwith this disease"},"899.84":{"start":"899.84","dur":"1","text":"die of their disease."},"900.84":{"start":"900.84","dur":"3.212","text":"And so given that really grim\nprognosis, the doctors who"},"904.05":{"start":"904.052","dur":"1.708","text":"were treating her went\nahead and gave her"},"905.76":{"start":"905.76","dur":"2.26","text":"some chemotherapy,\nthe [INAUDIBLE],"},"908.02":{"start":"908.02","dur":"2.144","text":"even though she didn&#39;t\nhave any cancer."},"910.16":{"start":"910.164","dur":"1.416","text":"And we call this\nadjuvant therapy."},"911.58":{"start":"911.58","dur":"1.374","text":"It&#39;s the type of\nchemotherapy you"},"912.95":{"start":"912.954","dur":"2.196","text":"give try to prevent the\ncancer from coming back."},"915.15":{"start":"915.15","dur":"3.22","text":"We do this very commonly in\nbreast cancer and in colon"},"918.37":{"start":"918.37","dur":"0.65","text":"cancer."},"919.02":{"start":"919.02","dur":"2.62","text":"But unfortunately, despite\ngetting this chemotherapy,"},"921.64":{"start":"921.64","dur":"2.58","text":"just a few months later,\nher cancer came back."},"924.22":{"start":"924.22","dur":"2.31","text":"It had now metastasized\nto the kidney."},"926.53":{"start":"926.53","dur":"4.18","text":"She now had metastases,\nand so spread to the lymph"},"930.71":{"start":"930.71","dur":"1.064","text":"nodes in the abdomen."},"931.77":{"start":"931.774","dur":"2.416","text":"And so what they went ahead\nand did is they actually went,"},"934.19":{"start":"934.19","dur":"1.46","text":"took her back to surgery."},"935.65":{"start":"935.65","dur":"1.465","text":"They cut all this\ncancer out again."},"937.12":{"start":"937.115","dur":"2.375","text":"Usually that doesn&#39;t work,\nbut they were really desperate"},"939.49":{"start":"939.49","dur":"1.481","text":"and had really no other options."},"940.97":{"start":"940.971","dur":"2.249","text":"And unfortunately, just a\nfew months later, the cancer"},"943.22":{"start":"943.22","dur":"1.56","text":"had come back again\nin the abdomen"},"944.78":{"start":"944.78","dur":"1.55","text":"and had now spread to the bone."},"946.33":{"start":"946.33","dur":"2.46","text":"And so this was really\nnot a good story."},"948.79":{"start":"948.79","dur":"3.05","text":"This is one that probably\nwas not going to end well."},"951.84":{"start":"951.84","dur":"2.53","text":"And so what we recommended\nis that we just"},"954.37":{"start":"954.37","dur":"2.37","text":"don&#39;t have good standard\ntreatments for you."},"956.74":{"start":"956.74","dur":"1.85","text":"We referred her for\na clinical trial,"},"958.59":{"start":"958.59","dur":"2.083","text":"and they referred her to\nwhat&#39;s called a phase one"},"960.67":{"start":"960.673","dur":"0.927","text":"clinical trial."},"961.60":{"start":"961.6","dur":"2.67","text":"This is really the first\n[? in-man ?] human study where"},"964.27":{"start":"964.27","dur":"2.38","text":"we&#39;re not even sure what&#39;s\nthe side effect of the drugs,"},"966.65":{"start":"966.65","dur":"1.57","text":"what&#39;s the right dose to give."},"968.22":{"start":"968.22","dur":"3.15","text":"And so she ultimately again,\nfor no particular reason"},"971.37":{"start":"971.37","dur":"2.06","text":"other than it was an\nopen study at the time,"},"973.43":{"start":"973.43","dur":"4.37","text":"was enrolled on the study of a\nchemotherapy called Irinotecan,"},"977.80":{"start":"977.8","dur":"3.09","text":"and a second drug\ncalled AZD7762,"},"980.89":{"start":"980.89","dur":"3.61","text":"which is an inhibitor of\na kinase-- or an enzyme,"},"984.50":{"start":"984.5","dur":"2.65","text":"you could say--\nwithin the cell that&#39;s"},"987.15":{"start":"987.15","dur":"2.48","text":"important for DNA\nrepair and checkpoint"},"989.63":{"start":"989.63","dur":"1.57","text":"to allow for DNA repair."},"991.20":{"start":"991.2","dur":"1.47","text":"And the hypothesis\nwith this trial"},"992.67":{"start":"992.67","dur":"3.76","text":"was that the cancer cells would\nbe more susceptible to DNA"},"996.43":{"start":"996.43","dur":"1.75","text":"damage from the chemotherapy."},"998.18":{"start":"998.18","dur":"3.76","text":"This kinase inhibitor would\nprevent this DNA repair"},"1001.94":{"start":"1001.94","dur":"3.04","text":"from happening in the\ncancer cells selectively,"},"1004.98":{"start":"1004.98","dur":"2.66","text":"and that would thus enhance the\neffects of the chemotherapy."},"1007.64":{"start":"1007.64","dur":"1.17","text":"And it was a good idea."},"1008.81":{"start":"1008.81","dur":"1.708","text":"There was some evidence\nin the laboratory"},"1010.52":{"start":"1010.518","dur":"1.142","text":"that this could work."},"1011.66":{"start":"1011.66","dur":"2.28","text":"But unfortunately, they\nsaw a lot of side effects"},"1013.94":{"start":"1013.94","dur":"1.35","text":"with this combination."},"1015.29":{"start":"1015.29","dur":"2.28","text":"And they really weren&#39;t\nseeing a lot of activities."},"1017.57":{"start":"1017.57","dur":"3.22","text":"So midway through treatment\non this clinical trial,"},"1020.79":{"start":"1020.79","dur":"2.9","text":"the company AstraZeneca\nactually discontinued"},"1023.69":{"start":"1023.69","dur":"0.98","text":"the entire program."},"1024.67":{"start":"1024.67","dur":"4.159","text":"So they stopped the\ndevelopment of this AZD7762."},"1028.83":{"start":"1028.829","dur":"3.381","text":"And that was despite the fact\nthat this patient had actually"},"1032.21":{"start":"1032.21","dur":"1.27","text":"achieved a complete response."},"1033.48":{"start":"1033.48","dur":"1.74","text":"So all her cancer had gone away."},"1035.22":{"start":"1035.22","dur":"1.71","text":"But she was really\nthe only one where"},"1036.93":{"start":"1036.93","dur":"2.83","text":"we saw that type of response."},"1039.76":{"start":"1039.76","dur":"3.64","text":"And so given the fact that they\nhad discontinued the program,"},"1043.40":{"start":"1043.4","dur":"1.679","text":"she had to stop taking the drug."},"1045.08":{"start":"1045.079","dur":"2.981","text":"They continued the chemotherapy\nfor a few more months,"},"1048.06":{"start":"1048.06","dur":"2.127","text":"eventually had to stop\nthat to give her a break."},"1050.19":{"start":"1050.187","dur":"2.583","text":"They were expecting the cancer\nwould come right back once they"},"1052.77":{"start":"1052.77","dur":"1.12","text":"stopped the treatment."},"1053.89":{"start":"1053.89","dur":"1.91","text":"And that was about\nfour years ago."},"1055.80":{"start":"1055.8","dur":"2","text":"Her cancer&#39;s never\ncome back and she&#39;s now"},"1057.80":{"start":"1057.8","dur":"2.09","text":"probably cured of her cancer."},"1059.89":{"start":"1059.89","dur":"2.81","text":"So again, this is a woman\nwho was cured of a cancer"},"1062.70":{"start":"1062.7","dur":"2.45","text":"that everybody dies\nof on a drug that"},"1065.15":{"start":"1065.15","dur":"2.32","text":"was so disappointing\nin the clinic"},"1067.47":{"start":"1067.47","dur":"3.24","text":"that the company discontinued it\nduring the first clinical trial"},"1070.71":{"start":"1070.71","dur":"0.91","text":"that was being done."},"1071.62":{"start":"1071.62","dur":"2.15","text":"So we went ahead and we\nsequenced this woman&#39;s"},"1073.77":{"start":"1073.77","dur":"1.59","text":"entire tumor genome."},"1075.36":{"start":"1075.36","dur":"1.55","text":"And this is called\na Circos plot."},"1076.91":{"start":"1076.91","dur":"2.55","text":"It&#39;s a way for us just\nto represent graphically"},"1079.46":{"start":"1079.46","dur":"1.67","text":"the complexity of\nher tumor genome."},"1081.13":{"start":"1081.13","dur":"2.9","text":"We just take the chromosomes,\nwe line them up in a circle."},"1084.03":{"start":"1084.03","dur":"3.58","text":"These line show translocations,\nso a breakage of one chromosome"},"1087.61":{"start":"1087.61","dur":"2.1","text":"where it&#39;s recombined\ninto another."},"1089.71":{"start":"1089.71","dur":"2.91","text":"This inner circle shows copy\nnumber alterations, so gains"},"1092.62":{"start":"1092.62","dur":"2.58","text":"or losses of particular genes."},"1095.20":{"start":"1095.2","dur":"4.17","text":"And then this woman actually\nhad 19,000 somatic mutations."},"1099.37":{"start":"1099.37","dur":"2.79","text":"These are alterations\nthat are in the tumor that"},"1102.16":{"start":"1102.16","dur":"1.7","text":"are not present in the normal."},"1103.86":{"start":"1103.86","dur":"3.35","text":"So again, how do we sort\nthrough all this information?"},"1107.21":{"start":"1107.21","dur":"2.83","text":"Just to give you some\nhints of how we do that."},"1110.04":{"start":"1110.04","dur":"4.83","text":"One thing we do is we can\nactually align these genes"},"1114.87":{"start":"1114.87","dur":"4.22","text":"to the homologues of these\ngenes in other species."},"1119.09":{"start":"1119.09","dur":"4.5","text":"So we can take particular genes\nthat are mutated informatically"},"1123.59":{"start":"1123.59","dur":"3.53","text":"and align them to the\nsame gene in a mouse,"},"1127.12":{"start":"1127.12","dur":"2.68","text":"or the same gene in\na Drosophila fly,"},"1129.80":{"start":"1129.8","dur":"3.24","text":"or the same gene in a yeast,\nor the same gene in a bacteria."},"1133.04":{"start":"1133.04","dur":"3.45","text":"And when you have areas\nwhere the gene is identical"},"1136.49":{"start":"1136.49","dur":"2.61","text":"in a human, in a mouse,\nin a dog, in a Drosophila,"},"1139.10":{"start":"1139.1","dur":"3.22","text":"in a yeast, in a bacteria,\nthat&#39;s a part of the gene"},"1142.32":{"start":"1142.32","dur":"3.71","text":"that you simply can&#39;t mutate\nwithout altering its function."},"1146.03":{"start":"1146.03","dur":"2.68","text":"So we can prioritize\nthat mutations"},"1148.71":{"start":"1148.71","dur":"2.08","text":"in that part of\nthe genome are more"},"1150.79":{"start":"1150.79","dur":"3.44","text":"likely to be functional or\ndisruptive of the protein&#39;s"},"1154.23":{"start":"1154.23","dur":"0.5","text":"function."},"1154.73":{"start":"1154.73","dur":"2.46","text":"And so when you go ahead and\ndo that, again we go back"},"1157.19":{"start":"1157.19","dur":"2.43","text":"and we take the 19,000\ngenes, we match them"},"1159.62":{"start":"1159.62","dur":"1.27","text":"up to the coding regions."},"1160.89":{"start":"1160.89","dur":"2.41","text":"We actually narrow it down\nto just a couple hundred"},"1163.30":{"start":"1163.3","dur":"0.79","text":"doing that."},"1164.09":{"start":"1164.09","dur":"2.24","text":"And then we take those\ncouple hundred candidates,"},"1166.33":{"start":"1166.33","dur":"1.47","text":"we align them evolutionarily."},"1167.80":{"start":"1167.8","dur":"3.44","text":"And when we do that, there was\na particular gene called RAD50"},"1171.24":{"start":"1171.24","dur":"1.44","text":"where there was a\nsingle base pair"},"1172.68":{"start":"1172.68","dur":"4.17","text":"substitution in that gene where\nit was in a part of the protein"},"1176.85":{"start":"1176.85","dur":"0.97","text":"called the D loop."},"1177.82":{"start":"1177.82","dur":"3.965","text":"And that part is essentially\nthe same in humans, in mice,"},"1181.79":{"start":"1181.785","dur":"2.875","text":"in Drosophila, in\nyeast, in bacteria."},"1184.66":{"start":"1184.66","dur":"3.97","text":"And so that really allowed us to\nprioritize this particular gene"},"1188.63":{"start":"1188.63","dur":"3.71","text":"mutation for further functional\nvalidation versus for example,"},"1192.34":{"start":"1192.34","dur":"2.15","text":"this ATR mutation,\nwhich was also"},"1194.49":{"start":"1194.49","dur":"2.2","text":"mutated in this\npatient&#39;s tumor but was"},"1196.69":{"start":"1196.69","dur":"2.63","text":"not in a known functional\narea of the protein"},"1199.32":{"start":"1199.32","dur":"3.28","text":"and was not in an area of\nevolutionary conservation."},"1202.60":{"start":"1202.6","dur":"2.59","text":"We can also take these\ndifferent genes that"},"1205.19":{"start":"1205.19","dur":"4.56","text":"are mutated and based upon\ncrystal structures of proteins"},"1209.75":{"start":"1209.75","dur":"2.45","text":"that have been made, we can\nactually model off the crystal"},"1212.20":{"start":"1212.2","dur":"2.27","text":"structure where the\nmutation is in the protein"},"1214.47":{"start":"1214.47","dur":"3.22","text":"and what this specific\namino acid substitution is"},"1217.69":{"start":"1217.69","dur":"3.33","text":"potentially going to do to the\ninteraction of that protein"},"1221.02":{"start":"1221.02","dur":"0.922","text":"with other proteins."},"1221.94":{"start":"1221.942","dur":"1.958","text":"And so this is just\nshowing in this patient who"},"1223.90":{"start":"1223.9","dur":"2.43","text":"had this unbelievable\ncurative response, that this"},"1226.33":{"start":"1226.33","dur":"3.5","text":"is a protein complex of actually\nthree different proteins called"},"1229.83":{"start":"1229.83","dur":"1.98","text":"the MRE complex."},"1231.81":{"start":"1231.81","dur":"2.16","text":"And this mutation in\nRAD50 would actually"},"1233.97":{"start":"1233.97","dur":"2.99","text":"be predicted to be on the\ninterface between RAD50"},"1236.96":{"start":"1236.96","dur":"2.66","text":"and another protein called\nMRE11, would actually"},"1239.62":{"start":"1239.62","dur":"2.054","text":"disrupt binding of\nthese two proteins,"},"1241.67":{"start":"1241.674","dur":"1.666","text":"and would actually\ndisrupt the function."},"1243.34":{"start":"1243.34","dur":"3.73","text":"So based upon again, this\nevolutionary conservation"},"1247.07":{"start":"1247.07","dur":"2.51","text":"and this crystal\nstructure modeling,"},"1249.58":{"start":"1249.58","dur":"2.76","text":"we&#39;re able to take\nthese 19,000 mutations"},"1252.34":{"start":"1252.34","dur":"1.93","text":"and really focus on\nthis one mutation that"},"1254.27":{"start":"1254.27","dur":"1.37","text":"seems most interesting."},"1255.64":{"start":"1255.64","dur":"2.62","text":"But even there, it&#39;s really\na computer prediction."},"1258.26":{"start":"1258.26","dur":"2.41","text":"It&#39;s a guess."},"1260.67":{"start":"1260.67","dur":"1.68","text":"And we still need to\ngo back to the lab"},"1262.35":{"start":"1262.35","dur":"1.87","text":"to do functional\nstudies to prove"},"1264.22":{"start":"1264.22","dur":"2.37","text":"that that hypothesis\nmakes a lot of sense."},"1266.59":{"start":"1266.59","dur":"3.11","text":"So what we did in this patient,\nto make a long story short,"},"1269.70":{"start":"1269.7","dur":"2.7","text":"is we took advantage of this\nevolutionary conservation"},"1272.40":{"start":"1272.4","dur":"1.88","text":"within this protein\nto actually do"},"1274.28":{"start":"1274.28","dur":"3.77","text":"a cross species validation of\nthis mutation in a yeast model."},"1278.05":{"start":"1278.05","dur":"3.21","text":"So because the yeast\nprotein for this pathway"},"1281.26":{"start":"1281.26","dur":"2","text":"is identical in\nhumans and in yeast,"},"1283.26":{"start":"1283.26","dur":"1.81","text":"we can knock this\nmutation into yeast"},"1285.07":{"start":"1285.07","dur":"2.13","text":"and see if it disrupts\nthe protein function"},"1287.20":{"start":"1287.2","dur":"2.7","text":"and whether it\nwould maybe explain"},"1289.90":{"start":"1289.9","dur":"2.02","text":"this woman&#39;s\nincredible sensitivity"},"1291.92":{"start":"1291.92","dur":"0.84","text":"to the chemotherapy."},"1292.76":{"start":"1292.76","dur":"2.137","text":"And so that&#39;s really\nthis experiment here."},"1294.90":{"start":"1294.897","dur":"1.833","text":"And what we&#39;re showing\nin this experiment is"},"1296.73":{"start":"1296.73","dur":"2.83","text":"if you knock in this\nRAD50 mutation into yeast-"},"1299.56":{"start":"1299.56","dur":"2.34","text":"and actually yeast just\nhave one copy of the genome,"},"1301.90":{"start":"1301.9","dur":"3.15","text":"these are haploid yeast--\nyou get some sensitization"},"1305.05":{"start":"1305.05","dur":"1.39","text":"to the chemotherapy here."},"1306.44":{"start":"1306.44","dur":"3.07","text":"But if you actually knock in\nthis RAD50 mutation and also"},"1309.51":{"start":"1309.51","dur":"1.53","text":"knock out the\ncheck one pathway--"},"1311.04":{"start":"1311.04","dur":"3.99","text":"and so MEC1 is the\nhomologue of ATR,"},"1315.03":{"start":"1315.03","dur":"2.557","text":"which activates\nupstream check one--"},"1317.59":{"start":"1317.587","dur":"1.833","text":"you get what&#39;s called\na synthetically lethal"},"1319.42":{"start":"1319.42","dur":"0.5","text":"interaction."},"1319.92":{"start":"1319.92","dur":"3.28","text":"So you see a killing\nof these cells"},"1323.20":{"start":"1323.2","dur":"2.79","text":"when you have both the RAD50\nmutation and knockout check"},"1325.99":{"start":"1325.99","dur":"2.39","text":"one when you give the\nchemotherapy that you don&#39;t see"},"1328.38":{"start":"1328.38","dur":"1.69","text":"when you give the\nchemotherapy to cells"},"1330.07":{"start":"1330.07","dur":"3","text":"that don&#39;t have this\nparticular mutation profile."},"1333.07":{"start":"1333.07","dur":"2.79","text":"So again, like the first\npatient I talked to you about,"},"1335.86":{"start":"1335.86","dur":"2.39","text":"this patient was\nthe perfect patient"},"1338.25":{"start":"1338.25","dur":"1.76","text":"for this combination of drugs."},"1340.01":{"start":"1340.01","dur":"2.31","text":"We simply didn&#39;t know it\ngoing into the clinical trial."},"1342.32":{"start":"1342.32","dur":"3.12","text":"But one could now hypothesize\nthat if we knew the mutation"},"1345.44":{"start":"1345.44","dur":"2.33","text":"status of all of\nthese patients going"},"1347.77":{"start":"1347.77","dur":"2.61","text":"into these clinical trials, we\ncould do these clinical trials"},"1350.38":{"start":"1350.38","dur":"2.68","text":"more effectively, hopefully\nget them done quicker,"},"1353.06":{"start":"1353.06","dur":"2.62","text":"and hopefully see better\nresults going forward."},"1355.68":{"start":"1355.68","dur":"2.61","text":"So this is really the paradigm\nof this extraordinary responder"},"1358.29":{"start":"1358.29","dur":"2.94","text":"initiative that&#39;s now gone\nnationwide through the National"},"1361.23":{"start":"1361.23","dur":"1.16","text":"Cancer Institute."},"1362.39":{"start":"1362.39","dur":"3.199","text":"We take a clinical trial\nwhich was disappointing,"},"1365.59":{"start":"1365.589","dur":"2.041","text":"but for which there were\nsome patients who seemed"},"1367.63":{"start":"1367.63","dur":"1.82","text":"to benefit from the treatment."},"1369.45":{"start":"1369.45","dur":"2","text":"We take tumors from\nthose patients."},"1371.45":{"start":"1371.45","dur":"1.78","text":"We do some sort of\ngenetic analysis"},"1373.23":{"start":"1373.23","dur":"3.037","text":"to figure out potentially what\nmade those patients unique."},"1376.27":{"start":"1376.267","dur":"1.583","text":"It&#39;s not showing up\non the slide here,"},"1377.85":{"start":"1377.85","dur":"2.76","text":"but we always go back\nto the laboratory"},"1380.61":{"start":"1380.61","dur":"3.39","text":"to do functional\nvalidation of that biology."},"1384.00":{"start":"1384","dur":"2.02","text":"And then what we need\nis we need an assay,"},"1386.02":{"start":"1386.02","dur":"2.92","text":"we need a test that will\nallow us to perspectively"},"1388.94":{"start":"1388.94","dur":"3.53","text":"now look for those particular\nmutations in everybody."},"1392.47":{"start":"1392.47","dur":"2.082","text":"So we know who has\nwhich mutations"},"1394.55":{"start":"1394.552","dur":"2.458","text":"so that we can do an iterative\nclinical trial where we just"},"1397.01":{"start":"1397.01","dur":"2.06","text":"enroll patients\nwith that mutation"},"1399.07":{"start":"1399.07","dur":"2.71","text":"onto this drug to ask how\nmany of them are going to have"},"1401.78":{"start":"1401.78","dur":"2.03","text":"similar type of responses."},"1403.81":{"start":"1403.81","dur":"2.4","text":"So how are we going\nto find the patients?"},"1406.21":{"start":"1406.21","dur":"2.4","text":"What is the assay\nthat we&#39;re going to do"},"1408.61":{"start":"1408.61","dur":"1.94","text":"to actually do this analysis?"},"1410.55":{"start":"1410.55","dur":"2.18","text":"And so this is what we&#39;re\ndoing at Sloan Kettering."},"1412.73":{"start":"1412.73","dur":"3.43","text":"We run an assay called\nMSK-IMPACT-- IMPACT standing"},"1416.16":{"start":"1416.16","dur":"2.62","text":"for Integrated Mutation\nProfiling of Actionable Cancer"},"1418.78":{"start":"1418.78","dur":"0.72","text":"Targets."},"1419.50":{"start":"1419.5","dur":"3.07","text":"And so this is an\nassay of 341 genes."},"1422.57":{"start":"1422.57","dur":"1.67","text":"And I took out the slide."},"1424.24":{"start":"1424.24","dur":"2.78","text":"And so what we know\nabout cancer is"},"1427.02":{"start":"1427.02","dur":"2.79","text":"that genes are not\nnecessarily distributed"},"1429.81":{"start":"1429.81","dur":"1.721","text":"in terms of the\nimportant mutations all"},"1431.53":{"start":"1431.531","dur":"1.249","text":"the way throughout the genome."},"1432.78":{"start":"1432.78","dur":"2.34","text":"That there&#39;s certain parts\nof the genome, certain cancer"},"1435.12":{"start":"1435.12","dur":"3.71","text":"genes, that are more likely\nto be important than others."},"1438.83":{"start":"1438.83","dur":"2.61","text":"And so what we can do\nto try to save costs,"},"1441.44":{"start":"1441.44","dur":"3.05","text":"to save money so that we\ncan sequence more patients"},"1444.49":{"start":"1444.49","dur":"3.92","text":"and get more from our sequencing\nresource, what we can do"},"1448.41":{"start":"1448.41","dur":"4.4","text":"is we can take DNA from multiple\npatients, we can chop it up,"},"1452.81":{"start":"1452.81","dur":"4.41","text":"we can then attach a DNA barcode\nto each of those individual DNA"},"1457.22":{"start":"1457.22","dur":"3.57","text":"molecules, and then mix all\nthose DNA molecules together"},"1460.79":{"start":"1460.79","dur":"2.02","text":"in the same reaction."},"1462.81":{"start":"1462.81","dur":"2.43","text":"And then we can use\nthose barcode DNAs"},"1465.24":{"start":"1465.24","dur":"2.37","text":"in a very powerful\ncomputer at the end"},"1467.61":{"start":"1467.61","dur":"2.71","text":"to actually figure out\nwhich DNA molecule came"},"1470.32":{"start":"1470.32","dur":"0.96","text":"from which patient."},"1471.28":{"start":"1471.28","dur":"2","text":"And so by mixing all these\nin the same reaction,"},"1473.28":{"start":"1473.28","dur":"1.91","text":"that allows us to save money."},"1475.19":{"start":"1475.19","dur":"3.026","text":"And I hope you&#39;ve\ngot a plug. [LAUGHS]"},"1478.22":{"start":"1478.216","dur":"1.124","text":"FEMALE SPEAKER: It&#39;s there."},"1479.34":{"start":"1479.34","dur":"0.9","text":"I don&#39;t know why it&#39;s not."},"1480.24":{"start":"1480.24","dur":"0.57","text":"Keep talking."},"1480.81":{"start":"1480.81","dur":"1.28","text":"DAVID B. SOLIT: OK."},"1482.09":{"start":"1482.09","dur":"2.67","text":"The other way we\nsave money is we"},"1484.76":{"start":"1484.76","dur":"2.43","text":"can actually pull down\nthe parts of the genome"},"1487.19":{"start":"1487.19","dur":"1.64","text":"that we&#39;re most interested in."},"1488.83":{"start":"1488.83","dur":"1.82","text":"So we develop dates."},"1490.65":{"start":"1490.65","dur":"2.98","text":"We develop DNA dates that\nwill go and hybridize"},"1493.63":{"start":"1493.63","dur":"3.11","text":"with the parts of the genome\nwhere the cancer mutations are"},"1496.74":{"start":"1496.74","dur":"1.78","text":"most likely to be found."},"1498.52":{"start":"1498.52","dur":"3.63","text":"And that again allows us to\nsave money on the sequencing"},"1502.15":{"start":"1502.15","dur":"1.92","text":"resource in the future."},"1504.07":{"start":"1504.07","dur":"1.57","text":"And so we&#39;ve\ndeveloped this assay."},"1505.64":{"start":"1505.64","dur":"1.223","text":"It&#39;s a custom assay."},"1506.86":{"start":"1506.863","dur":"0.687","text":"Yeah?"},"1507.55":{"start":"1507.55","dur":"0.5","text":"Yeah?"},"1508.05":{"start":"1508.05","dur":"1.13","text":"AUDIENCE: Question."},"1509.18":{"start":"1509.18","dur":"0.5","text":"[INAUDIBLE]"},"1513.52":{"start":"1513.52","dur":"2.35","text":"DAVID B. SOLIT: So this is\ncalled next-gen sequencing,"},"1515.87":{"start":"1515.87","dur":"2.08","text":"and it&#39;s really a\ndigital platform."},"1517.95":{"start":"1517.95","dur":"3.39","text":"So we sequence each individual\nDNA molecule separately."},"1521.34":{"start":"1521.34","dur":"3.38","text":"And what we try to do is try\nto sequence each of these DNA"},"1524.72":{"start":"1524.72","dur":"2.42","text":"molecules 500 or 1,000 times."},"1527.14":{"start":"1527.14","dur":"1.6","text":"And the reason that\nwe need to do that"},"1528.74":{"start":"1528.74","dur":"3.71","text":"is because the normal DNA is\nmixed in with the tumor DNA."},"1532.45":{"start":"1532.45","dur":"2.32","text":"We can&#39;t usually get\na pure population"},"1534.77":{"start":"1534.77","dur":"1.47","text":"of just cancer cells."},"1536.24":{"start":"1536.24","dur":"3.84","text":"And so if the tumor that we cut\nout from the patient and then"},"1540.08":{"start":"1540.08","dur":"2.15","text":"smushed up and\nextract the DNA out"},"1542.23":{"start":"1542.23","dur":"4.65","text":"of it, if that&#39;s 70% normal\ncells and 30% tumor cells,"},"1546.88":{"start":"1546.88","dur":"1.89","text":"we need to get\nbetter sensitivity"},"1548.77":{"start":"1548.77","dur":"1.56","text":"for finding the mutations."},"1550.33":{"start":"1550.33","dur":"1.54","text":"We want to have\nvery deep coverage."},"1551.87":{"start":"1551.87","dur":"2.93","text":"And that means sequencing\nthat same part of the genome"},"1554.80":{"start":"1554.8","dur":"2.74","text":"again and again and\nagain to make sure we"},"1557.54":{"start":"1557.54","dur":"1.14","text":"don&#39;t miss the mutation."},"1558.68":{"start":"1558.68","dur":"1.455","text":"Yeah."},"1560.14":{"start":"1560.135","dur":"1.455","text":"FEMALE SPEAKER: [INAUDIBLE]."},"1561.59":{"start":"1561.59","dur":"2.449","text":"DAVID B. SOLIT: So we&#39;ve\ncreated this initiative"},"1564.04":{"start":"1564.039","dur":"0.791","text":"at Sloan Kettering."},"1564.83":{"start":"1564.83","dur":"2.43","text":"And really the initiative\nis pretty simple."},"1567.26":{"start":"1567.26","dur":"2.14","text":"What we&#39;re trying\nto do here is we&#39;re"},"1569.40":{"start":"1569.4","dur":"2.47","text":"trying to sequence\nevery single patient"},"1571.87":{"start":"1571.87","dur":"3.19","text":"with advanced metastatic\ncancer at Sloan Kettering using"},"1575.06":{"start":"1575.06","dur":"0.61","text":"this assay."},"1575.67":{"start":"1575.67","dur":"4.52","text":"And so we see about\n45,000 unique patients"},"1580.19":{"start":"1580.19","dur":"2.86","text":"with cancer at Sloan\nKettering every single year."},"1583.05":{"start":"1583.05","dur":"2.83","text":"About 75% of these\npatients are cured."},"1585.88":{"start":"1585.88","dur":"3.1","text":"About a quarter of them\ndevelop recurrent disease"},"1588.98":{"start":"1588.98","dur":"2.49","text":"and are thus at highest risk\nof dying of their cancer"},"1591.47":{"start":"1591.47","dur":"2.501","text":"and thus the most in\nneed for novel therapies."},"1593.97":{"start":"1593.971","dur":"1.999","text":"And so we&#39;ve got about\n10,000 to 12,000 patients"},"1595.97":{"start":"1595.97","dur":"2.19","text":"like that at Sloan\nKettering every year."},"1598.16":{"start":"1598.16","dur":"2.7","text":"And so we are going\nto attempt, and we&#39;ve"},"1600.86":{"start":"1600.86","dur":"3.44","text":"begun this effort just\nover the past year,"},"1604.30":{"start":"1604.3","dur":"3.39","text":"use this assay to sequence every\nsingle one of those patients."},"1607.69":{"start":"1607.69","dur":"1.46","text":"We actually sequence\nboth the tumor"},"1609.15":{"start":"1609.15","dur":"1.96","text":"and we also sequence\nthe normal DNA."},"1611.11":{"start":"1611.11","dur":"2.72","text":"And by sequencing the normal\nDNA in all these genes,"},"1613.83":{"start":"1613.83","dur":"2.5","text":"there&#39;s actually the potential\nto identify a mutation that&#39;s"},"1616.33":{"start":"1616.33","dur":"2.12","text":"in the normal cells\nthat was actually"},"1618.45":{"start":"1618.45","dur":"2.87","text":"the reason that the patient got\nthe cancer in the first place."},"1621.32":{"start":"1621.32","dur":"2.15","text":"So genes like BRCA1\nor BRCA2, these"},"1623.47":{"start":"1623.47","dur":"2.75","text":"are risk factor genes that\nmake it more likely that you&#39;re"},"1626.22":{"start":"1626.22","dur":"1.27","text":"going to get cancer."},"1627.49":{"start":"1627.49","dur":"3.13","text":"What&#39;s the major\nhurdle to doing this?"},"1630.62":{"start":"1630.62","dur":"2.63","text":"Previously up to this\nyear, it was technology."},"1633.25":{"start":"1633.25","dur":"2.06","text":"But now it&#39;s really\nmoney, like many things."},"1635.31":{"start":"1635.31","dur":"3.82","text":"So it&#39;s very expensive\nto do the sequencing."},"1639.13":{"start":"1639.13","dur":"1.88","text":"And that&#39;s why I was\nfocusing on how can we"},"1641.01":{"start":"1641.01","dur":"2.845","text":"bring the cost of the\nsequencing down by mixing DNA"},"1643.86":{"start":"1643.855","dur":"2.125","text":"from multiple patients\ntogether and just sequencing"},"1645.98":{"start":"1645.98","dur":"2.07","text":"parts of the genome?"},"1648.05":{"start":"1648.05","dur":"4.6","text":"And it&#39;s both\nexpensive and it&#39;s not"},"1652.65":{"start":"1652.65","dur":"3.35","text":"standard to do this type\nof testing in most patients"},"1656.00":{"start":"1656","dur":"0.62","text":"with cancer."},"1656.62":{"start":"1656.62","dur":"2.27","text":"So we can only bill\ninsurance companies"},"1658.89":{"start":"1658.89","dur":"2.88","text":"to do this type of testing\nin six adult tumors."},"1661.77":{"start":"1661.77","dur":"2.22","text":"So patients with lung\ncancer, colorectal, melanoma,"},"1663.99":{"start":"1663.99","dur":"2.35","text":"GIST tumors,\nthyroid, and patients"},"1666.34":{"start":"1666.34","dur":"2.26","text":"with diffuse gliomas,\nwhich are brain cancers."},"1668.60":{"start":"1668.6","dur":"3.42","text":"So people with breast cancer,\nfolks with prostate cancer,"},"1672.02":{"start":"1672.02","dur":"2.9","text":"endometrial cancer, ovarian\ncancer, bladder cancer, these"},"1674.92":{"start":"1674.92","dur":"3.32","text":"are not tumors that we can\nget any sort of insurance"},"1678.24":{"start":"1678.24","dur":"2.32","text":"or Medicare reimbursement\nfor doing the sequencing."},"1680.56":{"start":"1680.56","dur":"2.795","text":"So to be able to do this\nsequencing, we need to go out"},"1683.36":{"start":"1683.355","dur":"1.125","text":"and we need to raise funds."},"1684.48":{"start":"1684.48","dur":"2.65","text":"And I&#39;m actually\nhere this weekend"},"1687.13":{"start":"1687.13","dur":"2.06","text":"riding with Cycle for\nSurvival to raise funds"},"1689.19":{"start":"1689.19","dur":"2.35","text":"to do this type of sequencing."},"1691.54":{"start":"1691.54","dur":"1.711","text":"And so our plan is to\ntry to do this as a"},"1693.25":{"start":"1693.251","dur":"1.749","text":"what we call a research\nnon billable test,"},"1695.00":{"start":"1695","dur":"2.91","text":"try to sequence everyone,\nand then use this information"},"1697.91":{"start":"1697.91","dur":"4.256","text":"to try to drive patients to\nthe most appropriate treatment."},"1702.17":{"start":"1702.166","dur":"1.874","text":"We&#39;ve also made a decision\nat Sloan Kettering"},"1704.04":{"start":"1704.04","dur":"2.51","text":"that we&#39;re going to make\nthe data that we generate"},"1706.55":{"start":"1706.55","dur":"3.61","text":"using this assay available\nto everyone at the Center"},"1710.16":{"start":"1710.16","dur":"0.82","text":"in real time."},"1710.98":{"start":"1710.98","dur":"3.61","text":"So what we&#39;ve done is we&#39;ve\ncreated this web-based portal"},"1714.59":{"start":"1714.59","dur":"2.5","text":"and database called the\ncBioPortal for Cancer Genomics."},"1717.09":{"start":"1717.09","dur":"1.97","text":"And there&#39;s both\na private version"},"1719.06":{"start":"1719.06","dur":"2.86","text":"of this portal and a public\nversion that you can access."},"1721.92":{"start":"1721.92","dur":"4.07","text":"But this is really almost cancer\nbioinformatics for dummies."},"1725.99":{"start":"1725.99","dur":"2.8","text":"It really is a\nway for biologists"},"1728.79":{"start":"1728.79","dur":"3.87","text":"who don&#39;t have a\ncomputational degree, maybe"},"1732.66":{"start":"1732.66","dur":"2.85","text":"knowledge of how to do\na Unix command prompt"},"1735.51":{"start":"1735.51","dur":"2.76","text":"or other training, to be\nable to browse this data."},"1738.27":{"start":"1738.27","dur":"2.7","text":"So if you&#39;re a clinician and\nyou&#39;re not an informatician,"},"1740.97":{"start":"1740.97","dur":"1.84","text":"or you&#39;re a biologist\nand just don&#39;t"},"1742.81":{"start":"1742.81","dur":"2.85","text":"have a bioinformatics\ndegree, this type of portal"},"1745.66":{"start":"1745.66","dur":"2.08","text":"lets you figure out\nvery quickly where"},"1747.74":{"start":"1747.74","dur":"2.36","text":"mutation&#39;s found in particular\ncancer types, what&#39;s"},"1750.10":{"start":"1750.1","dur":"2.78","text":"the co-mutation\npattern, how often"},"1752.88":{"start":"1752.88","dur":"1.66","text":"are those mutations found."},"1754.54":{"start":"1754.54","dur":"2.95","text":"And this data&#39;s now available\nto everyone at Sloan Kettering."},"1757.49":{"start":"1757.49","dur":"2.577","text":"And this is the summary\npage of that portal."},"1760.07":{"start":"1760.067","dur":"2.083","text":"And I just blew it up here\nso that you can see it."},"1762.15":{"start":"1762.15","dur":"3.35","text":"It lists how many of each\ncancer that we&#39;ve done."},"1765.50":{"start":"1765.5","dur":"4.05","text":"441 patients with breast\ncancer, 393 with lung cancer,"},"1769.55":{"start":"1769.55","dur":"2.69","text":"222 with colorectal,\nall down the line."},"1772.24":{"start":"1772.24","dur":"2.31","text":"And we&#39;re not just\ndoing common cancers."},"1774.55":{"start":"1774.55","dur":"1.66","text":"We&#39;re also doing\nvery rare cancers."},"1776.21":{"start":"1776.21","dur":"3.27","text":"We&#39;ve done one patient for\nexample with a Wilms&#39; tumor."},"1779.48":{"start":"1779.48","dur":"2.03","text":"This is a very rare\npediatric cancer."},"1781.51":{"start":"1781.51","dur":"3.31","text":"We&#39;ve done a couple patients\nwho have Fallopian tube cancers,"},"1784.82":{"start":"1784.82","dur":"1.41","text":"another very rare cancer."},"1786.23":{"start":"1786.23","dur":"3.59","text":"And so we&#39;re doing both common\ncancers and rare tumor types."},"1790.76":{"start":"1790.76","dur":"2.96","text":"There&#39;s a patient centered\nview for these tumors."},"1793.72":{"start":"1793.72","dur":"1.61","text":"And you can see this\nis a patient who"},"1795.33":{"start":"1795.33","dur":"3.88","text":"had a colorectal cancer which\nhad one of these BRAF mutations"},"1799.21":{"start":"1799.21","dur":"2.134","text":"that we now have a drug\nagainst that I mentioned"},"1801.34":{"start":"1801.344","dur":"1.166","text":"to you a little bit earlier."},"1802.51":{"start":"1802.51","dur":"2.28","text":"But the patient also has a\nnumber of other mutations"},"1804.79":{"start":"1804.79","dur":"1.5","text":"that are picked up by the assay."},"1806.29":{"start":"1806.29","dur":"2.43","text":"And so this type\nof sequencing may"},"1808.72":{"start":"1808.72","dur":"2.64","text":"allow us to understand\nmaybe why some patients"},"1811.36":{"start":"1811.36","dur":"3.16","text":"with BRAF reputations who\nget the BRAF inhibitor"},"1814.52":{"start":"1814.52","dur":"0.93","text":"do better than others."},"1815.45":{"start":"1815.45","dur":"2.49","text":"So some patients may\nhave a co-mutation"},"1817.94":{"start":"1817.94","dur":"3.09","text":"that makes their tumor\nless dependent upon BRAF"},"1821.03":{"start":"1821.03","dur":"3.21","text":"and thus less sensitive\nto that inhibitor."},"1824.24":{"start":"1824.24","dur":"3.54","text":"We&#39;ve also created\na database which"},"1827.78":{"start":"1827.78","dur":"2.91","text":"is out there to actually educate\nthe clinicians as to what"},"1830.69":{"start":"1830.69","dur":"1.07","text":"this information means."},"1831.76":{"start":"1831.76","dur":"4.35","text":"So many of the oncologists who\ntreat these patients really"},"1836.11":{"start":"1836.11","dur":"3.52","text":"just never got the\neducation in cancer genetics"},"1839.63":{"start":"1839.63","dur":"3.89","text":"to even understand what we&#39;re\ntalking about when we talk"},"1843.52":{"start":"1843.52","dur":"1.51","text":"about all these gene mutations."},"1845.03":{"start":"1845.03","dur":"4.712","text":"And so there&#39;s 20,000 plus\ngenes in the human genome."},"1849.74":{"start":"1849.742","dur":"1.458","text":"I don&#39;t know off\nthe top of my head"},"1851.20":{"start":"1851.2","dur":"2.55","text":"the four digit code for\nevery single one of those"},"1853.75":{"start":"1853.75","dur":"3.02","text":"and what that gene does."},"1856.77":{"start":"1856.77","dur":"2.79","text":"And so we almost\nneed a computer tool"},"1859.56":{"start":"1859.56","dur":"2.03","text":"to be able to, when\nthis data comes back,"},"1861.59":{"start":"1861.59","dur":"1.96","text":"be able to give us data."},"1863.55":{"start":"1863.55","dur":"2.77","text":"This gene has this\nfunction and when"},"1866.32":{"start":"1866.32","dur":"2.75","text":"you have this particular\nmutation in the gene, that&#39;s"},"1869.07":{"start":"1869.07","dur":"2.58","text":"a functional mutation\nand causes sensitivity"},"1871.65":{"start":"1871.65","dur":"1.02","text":"to a particular drug."},"1872.67":{"start":"1872.67","dur":"4.18","text":"So this database is something\nthat&#39;s a work in progress."},"1876.85":{"start":"1876.85","dur":"2.694","text":"But something that actually\ndoesn&#39;t exist publicly"},"1879.54":{"start":"1879.544","dur":"1.416","text":"is something we&#39;re\nactually hoping"},"1880.96":{"start":"1880.96","dur":"3.76","text":"maybe we can get together with\nother major cancer centers"},"1884.72":{"start":"1884.72","dur":"4.05","text":"and do a Wikipedia type of\nmodel where everybody puts"},"1888.77":{"start":"1888.77","dur":"3","text":"in their specific\nknowledge expertise"},"1891.77":{"start":"1891.77","dur":"2.78","text":"and eventually you\nthen crowd source"},"1894.55":{"start":"1894.55","dur":"3.61","text":"this sort of important\ndata for all 20,000"},"1898.16":{"start":"1898.16","dur":"1.45","text":"plus genes in the genome."},"1899.61":{"start":"1899.61","dur":"2.52","text":"But currently, we\nhave this data just"},"1902.13":{"start":"1902.13","dur":"1.88","text":"for the genes that\nwe have in our assay."},"1904.01":{"start":"1904.01","dur":"1.83","text":"And even there,\nit&#39;s only partial."},"1905.84":{"start":"1905.84","dur":"2.36","text":"So it&#39;s a real work in\nprogress, and a real problem."},"1908.20":{"start":"1908.2","dur":"2.88","text":"Because when this data comes\nback, most oncologists again,"},"1911.08":{"start":"1911.08","dur":"2.63","text":"they don&#39;t know what these\nparticular mutations mean"},"1913.71":{"start":"1913.71","dur":"1.98","text":"and what they do."},"1915.69":{"start":"1915.69","dur":"2.64","text":"So again, this is--\nyeah, go ahead."},"1918.33":{"start":"1918.33","dur":"3.09","text":"So if we actually go back\none slide here before this"},"1921.42":{"start":"1921.42","dur":"0.555","text":"comes up."},"1921.98":{"start":"1921.975","dur":"0.875","text":"AUDIENCE: [INAUDIBLE]"},"1922.85":{"start":"1922.85","dur":"0.34","text":"DAVID B. SOLIT: Yeah."},"1923.19":{"start":"1923.19","dur":"0.499","text":"Yeah."},"1923.69":{"start":"1923.689","dur":"2.321","text":"OK, so can we\ncompare our database"},"1926.01":{"start":"1926.01","dur":"3.55","text":"to 1000 Genomes or the\nSanger database and others?"},"1929.56":{"start":"1929.56","dur":"3.68","text":"And cBioPortal has become a\npublic database in some ways."},"1933.24":{"start":"1933.24","dur":"4.35","text":"So all the Tumor Cancer Genome\nAtlas that&#39;s publicly available"},"1937.59":{"start":"1937.59","dur":"2.66","text":"is now searchable\nin the cBioPortal."},"1940.25":{"start":"1940.25","dur":"1.45","text":"Other published\ndatabases are now"},"1941.70":{"start":"1941.7","dur":"1.36","text":"brought into the cBioPortal."},"1943.06":{"start":"1943.06","dur":"1.83","text":"And so this has\nactually become, I"},"1944.89":{"start":"1944.89","dur":"3.41","text":"think, the primary\ntool for most people"},"1948.30":{"start":"1948.3","dur":"3.39","text":"who are not cancer\nbioinformaticians to really"},"1951.69":{"start":"1951.69","dur":"1.96","text":"sort through the data."},"1953.65":{"start":"1953.65","dur":"4.15","text":"But you know, the problem\nis is that not everyone even"},"1957.80":{"start":"1957.8","dur":"3.04","text":"makes their data publicly\navailable in a way"},"1960.84":{"start":"1960.84","dur":"2.27","text":"that we can bring it\nin to these databases."},"1963.11":{"start":"1963.11","dur":"2.28","text":"So just to give you\none example, there&#39;s"},"1965.39":{"start":"1965.39","dur":"4.27","text":"a company that does germ line\ntesting for BRCA called Myriad."},"1969.66":{"start":"1969.66","dur":"5.78","text":"And they&#39;ve probably tested\nclose to 200,000 plus patients"},"1975.44":{"start":"1975.44","dur":"2.73","text":"with breast and ovarian\ncancer for these germ line"},"1978.17":{"start":"1978.17","dur":"0.63","text":"alterations."},"1978.80":{"start":"1978.8","dur":"2.59","text":"But they consider that\ndata to be proprietary."},"1981.39":{"start":"1981.39","dur":"3.46","text":"They don&#39;t release it, and\nso we don&#39;t have that data."},"1984.85":{"start":"1984.85","dur":"2.09","text":"So it really is\ngoing to be important"},"1986.94":{"start":"1986.94","dur":"3.92","text":"that anything public gets\ninto these type of databases."},"1990.86":{"start":"1990.86","dur":"2.94","text":"And it&#39;s not something that\na cancer center necessarily"},"1993.80":{"start":"1993.8","dur":"2.63","text":"was in the best position to do."},"1996.43":{"start":"1996.43","dur":"1.87","text":"I mean, that&#39;s\nnot our expertise."},"1998.30":{"start":"1998.3","dur":"4.052","text":"And so we&#39;ve created this\ninitiative at Sloan Kettering."},"2002.35":{"start":"2002.352","dur":"1.708","text":"But I&#39;ll tell you,\nwe&#39;d love to reach out"},"2004.06":{"start":"2004.06","dur":"4.11","text":"to people who have better\nexperience putting together"},"2008.17":{"start":"2008.17","dur":"4.94","text":"these type of databases to\nmake these tools even better."},"2013.11":{"start":"2013.11","dur":"2.47","text":"So I think that\nremains a problem."},"2015.58":{"start":"2015.58","dur":"2.89","text":"There&#39;s a lot of\nproprietary data out there,"},"2018.47":{"start":"2018.47","dur":"2.43","text":"but I think there&#39;s enough\nin the public domain"},"2020.90":{"start":"2020.9","dur":"3.58","text":"that if you really consolidated\nit into one source,"},"2024.48":{"start":"2024.48","dur":"3.08","text":"it would be incredibly valuable."},"2027.56":{"start":"2027.56","dur":"2.82","text":"So again, that&#39;s how we&#39;re\ngoing to find the mutations."},"2030.38":{"start":"2030.38","dur":"2.572","text":"And now I just want to\ntalk for a few minutes"},"2032.95":{"start":"2032.952","dur":"2.208","text":"about how are we going to\ndo the clinical trials that"},"2035.16":{"start":"2035.16","dur":"2.58","text":"are actually going to take this\ngenetic information to really"},"2037.74":{"start":"2037.74","dur":"1.69","text":"test these new drugs?"},"2039.43":{"start":"2039.43","dur":"1.95","text":"And so there&#39;s\nreally two main ways"},"2041.38":{"start":"2041.38","dur":"1.83","text":"we can do these clinical trials."},"2043.21":{"start":"2043.21","dur":"2.87","text":"One is called an umbrella\nprotocol or a master protocol."},"2046.08":{"start":"2046.08","dur":"1.96","text":"And these protocols\nare usually centered"},"2048.04":{"start":"2048.04","dur":"1.92","text":"around a particular cancer type."},"2049.96":{"start":"2049.96","dur":"3.38","text":"So this would be a master\nprotocol for patients with lung"},"2053.34":{"start":"2053.34","dur":"1.51","text":"cancer, as an example."},"2054.85":{"start":"2054.85","dur":"2.41","text":"And so what we do here is\nwe sequence all the patients"},"2057.26":{"start":"2057.26","dur":"2.879","text":"with lung cancer, maybe\nat multiple institutions."},"2060.14":{"start":"2060.139","dur":"2.52","text":"And then depending upon\nwhat mutation they have,"},"2062.66":{"start":"2062.659","dur":"2.431","text":"we put them on different\ndrugs based upon that."},"2065.09":{"start":"2065.09","dur":"2.21","text":"And many of the doctors\nlike this approach,"},"2067.30":{"start":"2067.3","dur":"1.71","text":"because as I mentioned\nearlier, it&#39;s"},"2069.01":{"start":"2069.01","dur":"2.45","text":"very hard to find the funds\nto sequence the patients."},"2071.46":{"start":"2071.46","dur":"2.17","text":"And so if you have a\nclinical trial like this,"},"2073.63":{"start":"2073.63","dur":"3.2","text":"you can ask the drug companies\nmaybe that make these drugs--"},"2076.83":{"start":"2076.83","dur":"2.97","text":"the EGFR inhibitor, the BRAF\ninhibitor, the MAC inhibitor--"},"2079.80":{"start":"2079.8","dur":"2.149","text":"to maybe pay for the sequencing."},"2081.95":{"start":"2081.949","dur":"2.285","text":"So this is one way\nthat we try to do this."},"2084.23":{"start":"2084.234","dur":"1.666","text":"And there are some\nmaster protocols open"},"2085.90":{"start":"2085.9","dur":"4.589","text":"for patients with lung cancer\nand some other tumor types."},"2090.49":{"start":"2090.489","dur":"2.15","text":"There&#39;s a few problems\nwith this approach though."},"2092.64":{"start":"2092.639","dur":"3.211","text":"One is that oftentimes\nit&#39;s not the same drug"},"2095.85":{"start":"2095.85","dur":"2.04","text":"company that makes each drug."},"2097.89":{"start":"2097.89","dur":"3.13","text":"And so drug company one might\nmake the EGFR inhibitor,"},"2101.02":{"start":"2101.02","dur":"2.08","text":"drug company two may\nmake the BRAF inhibitor,"},"2103.10":{"start":"2103.1","dur":"1.43","text":"and so on and so forth."},"2104.53":{"start":"2104.53","dur":"2.66","text":"So sometimes you can spend\na year or two negotiating"},"2107.19":{"start":"2107.19","dur":"1.5","text":"with different drug\ncompanies to get"},"2108.69":{"start":"2108.69","dur":"3.97","text":"the different drugs into this\none giganto clinical trial."},"2112.66":{"start":"2112.66","dur":"2.21","text":"And by the time you&#39;ve\nactually secured the drugs"},"2114.87":{"start":"2114.87","dur":"2.412","text":"and opened the trial, maybe\none or two of these drugs"},"2117.28":{"start":"2117.282","dur":"1.583","text":"have already failed\nin another context"},"2118.87":{"start":"2118.865","dur":"3.085","text":"and they&#39;re not really the best\nin class drug that&#39;s available."},"2121.95":{"start":"2121.95","dur":"2.23","text":"So that&#39;s one downside."},"2124.18":{"start":"2124.18","dur":"2.01","text":"The other downside\nI&#39;m going to focus on"},"2126.19":{"start":"2126.19","dur":"2.5","text":"is that oftentimes these\nare small clinical trials."},"2128.69":{"start":"2128.69","dur":"3.7","text":"And maybe you&#39;re sequencing\nin this clinical trial"},"2132.39":{"start":"2132.39","dur":"1.65","text":"200 patients."},"2134.04":{"start":"2134.04","dur":"2.08","text":"And if you&#39;ve got a\nmutation in the population"},"2136.12":{"start":"2136.12","dur":"2.79","text":"that you&#39;re studying\nthat&#39;s only 1% or 2% or 3%"},"2138.91":{"start":"2138.91","dur":"1.59","text":"of the population,\nyou&#39;re not going"},"2140.50":{"start":"2140.5","dur":"2.8","text":"to get enough patients\non to this clinical trial"},"2143.30":{"start":"2143.3","dur":"2.17","text":"with that particular\nmutation to really answer"},"2145.47":{"start":"2145.47","dur":"3.26","text":"the primary question, which\nis if you have this mutation,"},"2148.73":{"start":"2148.73","dur":"3.53","text":"do you respond to this specific\ninhibitor of that drug?"},"2152.26":{"start":"2152.26","dur":"2.09","text":"So that&#39;s one approach."},"2154.35":{"start":"2154.35","dur":"1.732","text":"But if you could find\nthe right patient ,"},"2156.08":{"start":"2156.082","dur":"1.958","text":"you can sometimes see\nthese incredible effects."},"2158.04":{"start":"2158.04","dur":"2.19","text":"This is a patient\nwith lung cancer."},"2160.23":{"start":"2160.23","dur":"4.21","text":"And actually in lung\ncancer, these BRAF mutations"},"2164.44":{"start":"2164.44","dur":"4.63","text":"I mentioned to you earlier only\nmake up about 1% to maybe 2%"},"2169.07":{"start":"2169.07","dur":"1.18","text":"of the population."},"2170.25":{"start":"2170.25","dur":"4.17","text":"But if you can find that rare\npatient who has a BRAF mutation"},"2174.42":{"start":"2174.42","dur":"1.84","text":"and give them the\nsame drug that works"},"2176.26":{"start":"2176.26","dur":"3.2","text":"in melanoma-- in this\ncase, [INAUDIBLE],"},"2179.46":{"start":"2179.46","dur":"1.746","text":"which is a selective\ninhibitor of RAF--"},"2181.21":{"start":"2181.206","dur":"1.874","text":"you can see these type\nof incredible effects."},"2183.08":{"start":"2183.08","dur":"4.42","text":"This is a patient who&#39;s been\non this drug for over two years"},"2187.50":{"start":"2187.5","dur":"3.24","text":"with a disease that most\npatients progress very quickly"},"2190.74":{"start":"2190.74","dur":"1.69","text":"and die within a year or two."},"2192.43":{"start":"2192.43","dur":"2.28","text":"So again, if you can\nmatch the right patient"},"2194.71":{"start":"2194.71","dur":"4.53","text":"on to the right drug by some\nmechanism, this can work."},"2199.24":{"start":"2199.24","dur":"3.31","text":"But for these rare mutations,\nthis type of master protocol"},"2202.55":{"start":"2202.55","dur":"2.964","text":"design is really inefficient."},"2205.51":{"start":"2205.514","dur":"2.166","text":"So what we&#39;ve tried to do\nis create a different type"},"2207.68":{"start":"2207.68","dur":"4.31","text":"of trial design that works for\nmutations where the mutation is"},"2211.99":{"start":"2211.99","dur":"1.85","text":"found in a lot of\ndifferent cancers,"},"2213.84":{"start":"2213.84","dur":"1.91","text":"but is not common\nin any of them."},"2215.75":{"start":"2215.75","dur":"1.93","text":"And so an example\nof that is a gene"},"2217.68":{"start":"2217.68","dur":"3.76","text":"called ERBB2, which is mutated\nin pretty much every different"},"2221.44":{"start":"2221.44","dur":"1.16","text":"cancer."},"2222.60":{"start":"2222.6","dur":"2.37","text":"But usually about\n1% or 2% or 3%."},"2224.97":{"start":"2224.97","dur":"1.64","text":"So there&#39;s a lot\nof these mutations."},"2226.61":{"start":"2226.61","dur":"1.79","text":"If you add them up,\nthere&#39;s probably"},"2228.40":{"start":"2228.4","dur":"2.97","text":"10,000 patients in\nthis country a year"},"2231.37":{"start":"2231.37","dur":"1.92","text":"who have a ERBB2 mutant tumor."},"2233.29":{"start":"2233.29","dur":"3.19","text":"But in most cancers, like\nbreast cancer, it&#39;s only 2%"},"2236.48":{"start":"2236.48","dur":"0.87","text":"of the population."},"2237.35":{"start":"2237.35","dur":"2.21","text":"So if you wanted\nto just test for it"},"2239.56":{"start":"2239.56","dur":"2.07","text":"and then enroll a\nbreast cancer trial,"},"2241.63":{"start":"2241.63","dur":"2.16","text":"you&#39;d have to test\n100 patients to find"},"2243.79":{"start":"2243.79","dur":"1.34","text":"two who have the mutation."},"2245.13":{"start":"2245.13","dur":"2.61","text":"And that&#39;s a very\ninefficient way to do that."},"2247.74":{"start":"2247.74","dur":"2.21","text":"So what we&#39;ve decided\nto do is we&#39;ve"},"2249.95":{"start":"2249.95","dur":"3.3","text":"created this new type of trial\nthat we call a basket trial."},"2253.25":{"start":"2253.25","dur":"2.03","text":"And what a basket\ntrial is it&#39;s a trial"},"2255.28":{"start":"2255.28","dur":"2.95","text":"that&#39;s focused around a specific\ngene or mutation and not"},"2258.23":{"start":"2258.23","dur":"1.13","text":"around a particular tumor."},"2259.36":{"start":"2259.36","dur":"2.58","text":"So we can take any patient."},"2261.94":{"start":"2261.94","dur":"2.3","text":"It doesn&#39;t matter what\nkind of cancer you have,"},"2264.24":{"start":"2264.24","dur":"2.225","text":"as long as you have the\nmutation we&#39;re interested in."},"2266.47":{"start":"2266.465","dur":"3.745","text":"And for this study of a\ndrug called Neratinib,"},"2270.21":{"start":"2270.21","dur":"2.24","text":"we&#39;re looking for patients\nwith a ERBB2 mutation."},"2272.45":{"start":"2272.45","dur":"2.458","text":"And it doesn&#39;t matter if you\nhave a bladder cancer or colon"},"2274.91":{"start":"2274.908","dur":"2.452","text":"cancer, an endometrial,\ngastric, ovarian, breast."},"2277.36":{"start":"2277.36","dur":"0.81","text":"It doesn&#39;t matter."},"2278.17":{"start":"2278.17","dur":"2.83","text":"If you have a ERBB2 mutation,\nyou can go on to the study."},"2281.00":{"start":"2281","dur":"2.03","text":"We always have another\narm for these studies"},"2283.03":{"start":"2283.03","dur":"2.39","text":"as well, because maybe\nthere&#39;s some other rare cancer"},"2285.42":{"start":"2285.42","dur":"3.08","text":"type that we didn&#39;t even\nknow had ERBB2 mutations."},"2288.50":{"start":"2288.5","dur":"2.04","text":"But we find one, we want\nto give the opportunity"},"2290.54":{"start":"2290.54","dur":"2.91","text":"to test whether that patient&#39;s\ngoing to respond to the drug."},"2293.45":{"start":"2293.45","dur":"2.56","text":"And we&#39;ve seen some incredible\nresponses with this approach."},"2296.01":{"start":"2296.01","dur":"4.36","text":"So this is a patient who has\none of these ERBB2 mutations."},"2300.37":{"start":"2300.37","dur":"3.22","text":"And we generally don&#39;t test\nfor these mutations in breast"},"2303.59":{"start":"2303.59","dur":"1.58","text":"cancer, which is what she has."},"2305.17":{"start":"2305.17","dur":"2.13","text":"And this is a woman who&#39;d\nbeen through many lines"},"2307.30":{"start":"2307.3","dur":"1.83","text":"of chemotherapy,\nnone of which were"},"2309.13":{"start":"2309.13","dur":"4.084","text":"working because they weren&#39;t\ntargeting the right mutation."},"2313.21":{"start":"2313.214","dur":"1.416","text":"And you can see\nfrom her PET scan,"},"2314.63":{"start":"2314.63","dur":"2.59","text":"she had this incredibly\nhigh burden of disease."},"2317.22":{"start":"2317.22","dur":"3.29","text":"All of these are actually\nmetastasis from her cancer."},"2320.51":{"start":"2320.51","dur":"2.857","text":"This is her brain,\nthis is her bladder."},"2323.37":{"start":"2323.367","dur":"1.833","text":"Some of this is her\nheart, but most of these"},"2325.20":{"start":"2325.2","dur":"0.75","text":"are all mutations."},"2325.95":{"start":"2325.95","dur":"2.31","text":"And actually see less\nuptake in the heart"},"2328.26":{"start":"2328.26","dur":"2.27","text":"because so much of the PET\ntracer here-- the glucose"},"2330.53":{"start":"2330.53","dur":"2.82","text":"that we inject, the\nradioactive glucose tracer--"},"2333.35":{"start":"2333.35","dur":"1.53","text":"is going up in the tumor."},"2334.88":{"start":"2334.88","dur":"2.38","text":"And so she was started on\nthis drug on this basket study"},"2337.26":{"start":"2337.26","dur":"1.67","text":"in July of 2004."},"2338.93":{"start":"2338.93","dur":"2.88","text":"Within two months, she&#39;s\nhad a complete response."},"2341.81":{"start":"2341.81","dur":"3.97","text":"But the key issue here is\nnot that it&#39;s surprising"},"2345.78":{"start":"2345.78","dur":"3.18","text":"that this ERBB2 inhibitor,\nwhich is what Neratinib is,"},"2348.96":{"start":"2348.96","dur":"2.01","text":"would work in this\nERBB2 mutant patient."},"2350.97":{"start":"2350.97","dur":"2.07","text":"The real problem is that\nalmost all patients who"},"2353.04":{"start":"2353.04","dur":"5.28","text":"have this mutation-- this V77L\nmissense mutation in ERBB2--"},"2358.32":{"start":"2358.32","dur":"2.44","text":"are unaware that they\nhave this mutation"},"2360.76":{"start":"2360.76","dur":"1.96","text":"because we don&#39;t test\nfor this mutation."},"2362.72":{"start":"2362.72","dur":"2.999","text":"So since nobody&#39;s testing for\nit, we can&#39;t find the patients."},"2365.72":{"start":"2365.719","dur":"1.791","text":"We can&#39;t put them on\nthe trial and we can&#39;t"},"2367.51":{"start":"2367.51","dur":"1.083","text":"prove that the drug works."},"2368.59":{"start":"2368.593","dur":"2.167","text":"So it&#39;s really a chicken\nand the egg problem."},"2370.76":{"start":"2370.76","dur":"2.68","text":"How do you prove the drug\nworks without knowing"},"2373.44":{"start":"2373.44","dur":"1.4","text":"who has the mutation?"},"2374.84":{"start":"2374.84","dur":"3.22","text":"How can you actually justify\ndoing the testing unless you"},"2378.06":{"start":"2378.06","dur":"1.214","text":"know that the drug works?"},"2379.27":{"start":"2379.274","dur":"1.666","text":"Because otherwise,\nthe insurance company"},"2380.94":{"start":"2380.94","dur":"1.36","text":"won&#39;t pay for the testing."},"2382.30":{"start":"2382.3","dur":"3.13","text":"And so to try to break this\nchicken and the egg cycle,"},"2385.43":{"start":"2385.43","dur":"2.31","text":"we&#39;ve just made this\ncommitment that we"},"2387.74":{"start":"2387.74","dur":"3.86","text":"are going to test everyone using\ninstitutional funds until we"},"2391.60":{"start":"2391.6","dur":"4.28","text":"can essentially enroll enough\npatients onto these trials"},"2395.88":{"start":"2395.88","dur":"2.44","text":"to prove that these\ndrugs work or don&#39;t work."},"2398.32":{"start":"2398.32","dur":"3.07","text":"It&#39;s a little more complicated\nthan I&#39;m making it out to be."},"2401.39":{"start":"2401.39","dur":"2.64","text":"There are multiple different\nERBB2 mutations in cancer."},"2404.03":{"start":"2404.03","dur":"2.73","text":"They may all respond a little\nbit differently to the drug."},"2406.76":{"start":"2406.76","dur":"2.31","text":"And so what we do with the\nbasket study, for example,"},"2409.07":{"start":"2409.07","dur":"1.83","text":"is we can take this\nbreast cancer arm."},"2410.90":{"start":"2410.9","dur":"2.96","text":"We can initially enroll all the\npatients with ERBB2 mutations."},"2413.86":{"start":"2413.86","dur":"2.1","text":"Since we&#39;ve already\nseen a positive result"},"2415.96":{"start":"2415.96","dur":"3.46","text":"on the overall arm, we\ncan then do sub-baskets"},"2419.42":{"start":"2419.42","dur":"2.48","text":"where we enroll a\ncohort of patients"},"2421.90":{"start":"2421.9","dur":"3.35","text":"that have this S310 mutation,\na cohort of patients"},"2425.25":{"start":"2425.25","dur":"4.469","text":"with an L755 mutation, a cohort\nwith V77L on down the line."},"2429.72":{"start":"2429.719","dur":"1.541","text":"And again, we always\nhave another arm"},"2431.26":{"start":"2431.26","dur":"1.85","text":"for these rare\nmutations to give access"},"2433.11":{"start":"2433.11","dur":"1.8","text":"to the drug to these patients."},"2434.91":{"start":"2434.91","dur":"2.61","text":"And the question is, can we\neventually get to a point"},"2437.52":{"start":"2437.52","dur":"3.88","text":"where we&#39;ve got a rare\nenough mutation disease"},"2441.40":{"start":"2441.4","dur":"3.47","text":"combination where almost\neverybody&#39;s responding"},"2444.87":{"start":"2444.87","dur":"3.15","text":"that the FDA would simply allow\nus to change standard of care"},"2448.02":{"start":"2448.02","dur":"0.77","text":"at that point?"},"2448.79":{"start":"2448.79","dur":"3.19","text":"So typically, the FDA has\nrequired us, for cancer drugs,"},"2451.98":{"start":"2451.98","dur":"1.08","text":"to do randomized studies."},"2453.06":{"start":"2453.06","dur":"3.66","text":"Where one half of the\npatients or so get the drug,"},"2456.72":{"start":"2456.72","dur":"3.01","text":"the other half get a placebo\nor an older standard drug"},"2459.73":{"start":"2459.73","dur":"1.75","text":"that doesn&#39;t work very well."},"2461.48":{"start":"2461.48","dur":"1.53","text":"And the question\nis, can we avoid"},"2463.01":{"start":"2463.01","dur":"3.44","text":"those type of randomized studies\nby very carefully selecting"},"2466.45":{"start":"2466.45","dur":"4.4","text":"the patients so that the benefit\nis so high on a small study"},"2470.85":{"start":"2470.85","dur":"4.07","text":"that it compels the community\nto just change standard of care?"},"2474.92":{"start":"2474.92","dur":"3.18","text":"Because you could imagine if we\nwere seeing this type of result"},"2478.10":{"start":"2478.1","dur":"1.82","text":"in 80% or 90% percent\nof the patients"},"2479.92":{"start":"2479.92","dur":"2.51","text":"with this mutation\nin breast cancer,"},"2482.43":{"start":"2482.43","dur":"2.81","text":"a patient with that exact\nmutation in breast cancer"},"2485.24":{"start":"2485.24","dur":"1.74","text":"doesn&#39;t want to go on a placebo."},"2486.98":{"start":"2486.98","dur":"3.26","text":"And it might sound ridiculous to\neven consider that possibility."},"2490.24":{"start":"2490.24","dur":"3.02","text":"But the [INAUDIBLE] study that\nI told you about earlier was"},"2493.26":{"start":"2493.26","dur":"1.096","text":"that exact situation."},"2494.36":{"start":"2494.356","dur":"1.374","text":"And despite that,\nwe actually had"},"2495.73":{"start":"2495.73","dur":"2.9","text":"to do a placebo controlled\nstudy by the FDA."},"2498.63":{"start":"2498.63","dur":"2.855","text":"In that case, there were enough\npatients to do that trial."},"2501.49":{"start":"2501.485","dur":"2.375","text":"I don&#39;t even think there&#39;s\nenough patients in the country"},"2503.86":{"start":"2503.86","dur":"4.5","text":"to do a placebo controlled study\nof just V77L ERBB2 mutations"},"2508.36":{"start":"2508.36","dur":"0.7","text":"with Neratinib."},"2509.06":{"start":"2509.06","dur":"3.78","text":"So hopefully, the regulators\nwill accept this and change"},"2512.84":{"start":"2512.84","dur":"0.98","text":"the way we do things."},"2513.82":{"start":"2513.82","dur":"1.49","text":"Question?"},"2515.31":{"start":"2515.31","dur":"2.05","text":"So I guess the\nquestion was are we"},"2517.36":{"start":"2517.36","dur":"3.46","text":"potentially missing important\nmutations or other alterations"},"2520.82":{"start":"2520.82","dur":"5.16","text":"by just sequencing the 410\ngenes that our current assay is"},"2525.98":{"start":"2525.98","dur":"0.73","text":"looking at?"},"2526.71":{"start":"2526.71","dur":"2.38","text":"And the answer is\nabsolutely correct."},"2529.09":{"start":"2529.09","dur":"4.82","text":"But my initial answer that\nquestion would be this"},"2533.91":{"start":"2533.91","dur":"2.06","text":"is an example of not\nletting the perfect be"},"2535.97":{"start":"2535.97","dur":"0.96","text":"the enemy of the good."},"2536.93":{"start":"2536.93","dur":"3.18","text":"So since we can&#39;t do\nwhole genome sequencing"},"2540.11":{"start":"2540.11","dur":"3.39","text":"on every single\npatient, that shouldn&#39;t"},"2543.50":{"start":"2543.5","dur":"3.7","text":"prevent us to do 410 genes\non every single patient."},"2547.20":{"start":"2547.2","dur":"3.68","text":"So we&#39;re doing what we&#39;re\nfeasibly able to do right now."},"2550.88":{"start":"2550.88","dur":"3.91","text":"But the expectation is\nthat this sequencing"},"2554.79":{"start":"2554.79","dur":"2.51","text":"is going to become\ncheaper over time,"},"2557.30":{"start":"2557.3","dur":"2.22","text":"and the computational\npower to do the analysis"},"2559.52":{"start":"2559.52","dur":"2.13","text":"gets cheaper and\nquicker over time."},"2561.65":{"start":"2561.65","dur":"2.29","text":"And everybody I&#39;m\nsure in this room"},"2563.94":{"start":"2563.94","dur":"2.34","text":"knows of Moore&#39;s Law,\nwhich is the rate"},"2566.28":{"start":"2566.28","dur":"3.56","text":"at which computational power\nbecomes more powerful and less"},"2569.84":{"start":"2569.84","dur":"1.18","text":"expensive."},"2571.02":{"start":"2571.02","dur":"3.77","text":"The rate at which sequencing\nis becoming more powerful"},"2574.79":{"start":"2574.79","dur":"2","text":"is actually much\ndramatically faster"},"2576.79":{"start":"2576.79","dur":"2.99","text":"than what you see with Moore&#39;s\nLaw with semiconductors."},"2579.78":{"start":"2579.78","dur":"3.42","text":"So we&#39;re seeing this\nincredibly fast drop"},"2583.20":{"start":"2583.2","dur":"1.09","text":"in the cost of sequencing."},"2584.29":{"start":"2584.29","dur":"1.5","text":"And there&#39;s companies\nlike Illumina"},"2585.79":{"start":"2585.79","dur":"2.32","text":"and others that are\nmaking these machines that"},"2588.11":{"start":"2588.11","dur":"1.26","text":"are driving this improvement."},"2589.37":{"start":"2589.37","dur":"2.24","text":"And it&#39;s probably\na few years away"},"2591.61":{"start":"2591.61","dur":"2.46","text":"from a point where we will\nbe getting that whole genome"},"2594.07":{"start":"2594.07","dur":"1.75","text":"sequence on every patient."},"2595.82":{"start":"2595.82","dur":"2.25","text":"We just feasibly\ncan&#39;t do it now."},"2598.07":{"start":"2598.07","dur":"1.524","text":"But there are\nprobably some patients"},"2599.59":{"start":"2599.594","dur":"2.416","text":"who are going out and having\ntheir whole genome sequenced."},"2602.01":{"start":"2602.01","dur":"3.01","text":"There might be a few\npatients of means that can"},"2605.02":{"start":"2605.02","dur":"2.63","text":"convince somebody to do that."},"2607.65":{"start":"2607.65","dur":"3.53","text":"My lab does it in this\nretrospective approach"},"2611.18":{"start":"2611.18","dur":"2.48","text":"for these rare,\nextraordinary responders."},"2613.66":{"start":"2613.66","dur":"5.25","text":"But each one of those not only\ncosts the lab tens of thousands"},"2618.91":{"start":"2618.91","dur":"2.52","text":"of dollars to do,\nbut it takes actually"},"2621.43":{"start":"2621.43","dur":"3.999","text":"a team of informaticians\nweeks to do the analysis."},"2625.43":{"start":"2625.429","dur":"1.541","text":"So we need the cost\nof the sequencing"},"2626.97":{"start":"2626.97","dur":"1.69","text":"to come down and\nthen what we need"},"2628.66":{"start":"2628.66","dur":"2.93","text":"is better algorithmic\napproaches for the analysis"},"2631.59":{"start":"2631.59","dur":"2.9","text":"so that you can take these\nbillions of data points"},"2634.49":{"start":"2634.49","dur":"2.34","text":"and be able to analyze\nthem much more quickly."},"2636.83":{"start":"2636.83","dur":"1.6","text":"And one way to do\nthat is to have"},"2638.43":{"start":"2638.43","dur":"2.92","text":"this central database\nof all known variant"},"2641.35":{"start":"2641.35","dur":"2.63","text":"changes that you&#39;re\nable to reference."},"2643.98":{"start":"2643.98","dur":"1.6","text":"And so the fact\nthat we&#39;ve only done"},"2645.58":{"start":"2645.58","dur":"2.04","text":"a small number of\nwhole genomes so far"},"2647.62":{"start":"2647.62","dur":"2.75","text":"make it difficult for us\nto know whether something"},"2650.37":{"start":"2650.37","dur":"2.25","text":"found in a particular\ngenome is important."},"2652.62":{"start":"2652.62","dur":"2.01","text":"Because the more you\ndo, the more often you"},"2654.63":{"start":"2654.63","dur":"2.7","text":"see these patterns\nthat allow you to know"},"2657.33":{"start":"2657.33","dur":"1.835","text":"that something is real or not."},"2659.17":{"start":"2659.165","dur":"2.925","text":"But it&#39;s a great question."},"2662.09":{"start":"2662.09","dur":"2.6","text":"So what are the advantages\nof this basket approach?"},"2664.69":{"start":"2664.69","dur":"4.56","text":"I&#39;m a clinician, but I&#39;m also a\ncancer biologist, a geneticist."},"2669.25":{"start":"2669.25","dur":"1.6","text":"What this allows\nus to do is really"},"2670.85":{"start":"2670.85","dur":"1.98","text":"test that defined\nbiologic hypothesis."},"2672.83":{"start":"2672.83","dur":"4.98","text":"Does a ERBB2 inhibitor work in\npatients with a ERBB2 mutation?"},"2677.81":{"start":"2677.81","dur":"1.69","text":"How often does it work?"},"2679.50":{"start":"2679.5","dur":"2.55","text":"If it works in some\npatients and not others,"},"2682.05":{"start":"2682.05","dur":"2.08","text":"we can collect tumors\nfrom all those patients,"},"2684.13":{"start":"2684.13","dur":"1.65","text":"we can maybe do whole\ngenome sequencing"},"2685.78":{"start":"2685.78","dur":"2.53","text":"in that whole cohort,\nand figure out"},"2688.31":{"start":"2688.31","dur":"3.37","text":"what are the co-mutations that\ndetermine that heterogeneity"},"2691.68":{"start":"2691.68","dur":"2.939","text":"within even that small class."},"2694.62":{"start":"2694.619","dur":"1.541","text":"We&#39;re also doing on\nthis trial what&#39;s"},"2696.16":{"start":"2696.16","dur":"3.51","text":"called a co-clinical trial,\nwhere we enroll patients not"},"2699.67":{"start":"2699.67","dur":"1.57","text":"just with known\nactivating mutations"},"2701.24":{"start":"2701.24","dur":"3.02","text":"but also patients who have novel\nmutations that have never been"},"2704.26":{"start":"2704.26","dur":"1.471","text":"biologically characterized."},"2705.73":{"start":"2705.731","dur":"1.749","text":"And what we do is while\nthose patients are"},"2707.48":{"start":"2707.48","dur":"1.92","text":"on the clinical\ntrial, we biologically"},"2709.40":{"start":"2709.4","dur":"2.14","text":"characterize those\nmutations in the laboratory."},"2711.54":{"start":"2711.54","dur":"2.45","text":"And we may find that\nfor some of them,"},"2713.99":{"start":"2713.99","dur":"1.6","text":"they&#39;re not\nfunctional mutations."},"2715.59":{"start":"2715.59","dur":"2.47","text":"So if I go back to this\nslide of ERBB2 mutations,"},"2718.06":{"start":"2718.06","dur":"2.88","text":"these hot spots have now all\nbeen biologically validated"},"2720.94":{"start":"2720.94","dur":"1","text":"and are real."},"2721.94":{"start":"2721.94","dur":"2.81","text":"As we get more and\nmore sequencing data,"},"2724.75":{"start":"2724.75","dur":"2.779","text":"some of these rare mutations\nwill become hot spots."},"2727.53":{"start":"2727.529","dur":"2.541","text":"But some of these are just what\nwe call passenger mutations--"},"2730.07":{"start":"2730.07","dur":"2.88","text":"the random changes in the\nDNA due to the toxin that"},"2732.95":{"start":"2732.95","dur":"2.63","text":"induced the DNA damage."},"2735.58":{"start":"2735.58","dur":"2.019","text":"And they&#39;re not\ndriving the cancer."},"2737.60":{"start":"2737.599","dur":"1.791","text":"And so we don&#39;t have\nthat knowledge for all"},"2739.39":{"start":"2739.39","dur":"1.6","text":"of these mutations so far."},"2740.99":{"start":"2740.99","dur":"2.029","text":"We just have it for\nthe most common."},"2743.02":{"start":"2743.019","dur":"1.541","text":"But as patients come\non to the study,"},"2744.56":{"start":"2744.56","dur":"2.48","text":"we study individual mutations\nthat have not already"},"2747.04":{"start":"2747.04","dur":"1.53","text":"been validated."},"2748.57":{"start":"2748.57","dur":"1.76","text":"What are the challenges\nwith the approach?"},"2750.33":{"start":"2750.33","dur":"3.69","text":"The primary criticism we\nget from drug companies,"},"2754.02":{"start":"2754.02","dur":"2.96","text":"clinicians,\nregulators, is that we"},"2756.98":{"start":"2756.98","dur":"2.22","text":"fail to identify patients\nwho could respond"},"2759.20":{"start":"2759.2","dur":"2.25","text":"but they don&#39;t have the\nbio-marker we&#39;re testing."},"2761.45":{"start":"2761.45","dur":"1.917","text":"So in the case of ERBB2,\nyou don&#39;t necessarily"},"2763.37":{"start":"2763.367","dur":"2.333","text":"have to have a ERBB2 mutation\nto benefit from Neratinib."},"2765.70":{"start":"2765.7","dur":"1.25","text":"We actually know that&#39;s true."},"2766.95":{"start":"2766.95","dur":"3.786","text":"Maybe you can have an activated\nreceptor from a ligand"},"2770.74":{"start":"2770.736","dur":"0.624","text":"that&#39;s binding."},"2771.36":{"start":"2771.36","dur":"2.34","text":"So while that&#39;s true, it&#39;s\nnot the point of the study,"},"2773.70":{"start":"2773.7","dur":"3.21","text":"and we can always study those\nthings in later studies."},"2776.91":{"start":"2776.91","dur":"3.637","text":"I call it the sad fact,\nand that&#39;s in academia,"},"2780.55":{"start":"2780.547","dur":"2.333","text":"it&#39;s sometimes difficult to\nget the lung doctors to work"},"2782.88":{"start":"2782.88","dur":"2.458","text":"with the colon doctors to get\nthem to work with the bladder"},"2785.34":{"start":"2785.338","dur":"0.612","text":"doctors."},"2785.95":{"start":"2785.95","dur":"2.5","text":"They&#39;re actually not used to\ndoing clinical trials that way."},"2788.45":{"start":"2788.45","dur":"2.86","text":"So the way they train, the\nway they practice over decades"},"2791.31":{"start":"2791.31","dur":"1.88","text":"is you just do\nbreast cancer trials,"},"2793.19":{"start":"2793.19","dur":"2.29","text":"and they&#39;re separate than\ndoing lung cancer trials,"},"2795.48":{"start":"2795.48","dur":"1.875","text":"and they&#39;re separate\nthan doing colon trials."},"2797.36":{"start":"2797.355","dur":"3.365","text":"And the concept of doing a\ntrial where any type of cancer"},"2800.72":{"start":"2800.72","dur":"2.03","text":"can be in that trial\nis something that&#39;s"},"2802.75":{"start":"2802.75","dur":"2.32","text":"foreign to the community."},"2805.07":{"start":"2805.07","dur":"2.17","text":"But I think that&#39;s starting\nto change with some"},"2807.24":{"start":"2807.24","dur":"1.11","text":"of the success we&#39;ve seen."},"2808.35":{"start":"2808.35","dur":"1.5","text":"And again, I&#39;m just\ngoing to mention"},"2809.85":{"start":"2809.85","dur":"3.25","text":"that the primary hurdle really\nremains that identifying"},"2813.10":{"start":"2813.1","dur":"1.95","text":"the patients is a challenge."},"2815.05":{"start":"2815.05","dur":"2.44","text":"The vast majority of patients\nwith cancer in this country"},"2817.49":{"start":"2817.49","dur":"1.75","text":"don&#39;t get any testing."},"2819.24":{"start":"2819.24","dur":"2.29","text":"There&#39;s only a few institutions\ndoing this right now."},"2821.53":{"start":"2821.53","dur":"3.8","text":"The scale, that number is going\nto keep going up over time."},"2825.33":{"start":"2825.33","dur":"2.5","text":"But most patients in the\ncommunity don&#39;t get this."},"2827.83":{"start":"2827.83","dur":"3.73","text":"There are some companies that\nare now specifically opening up"},"2831.56":{"start":"2831.56","dur":"1.27","text":"to do this type of testing."},"2832.83":{"start":"2832.83","dur":"2.03","text":"One&#39;s called\nFoundation Medicine."},"2834.86":{"start":"2834.86","dur":"3.46","text":"They charge $5,800 for the\ntest, and generally insurance"},"2838.32":{"start":"2838.32","dur":"0.64","text":"doesn&#39;t cover."},"2838.96":{"start":"2838.96","dur":"3.39","text":"So for most patients,\nit&#39;s not really"},"2842.35":{"start":"2842.35","dur":"3.51","text":"feasible to get\nthis test performed."},"2845.86":{"start":"2845.86","dur":"1.444","text":"I just have two more slides."},"2847.30":{"start":"2847.304","dur":"2.166","text":"I just want to point out\nthat the testing&#39;s not just"},"2849.47":{"start":"2849.47","dur":"3.17","text":"for selection of what we call\ntargeted therapies, which"},"2852.64":{"start":"2852.64","dur":"3.23","text":"are drugs that inhibit a\nspecific mutant protein."},"2855.87":{"start":"2855.87","dur":"2.61","text":"This was one of the\nfirst patients of mine"},"2858.48":{"start":"2858.48","dur":"3.37","text":"that I see in the clinic\nwhich I did this testing for."},"2861.85":{"start":"2861.85","dur":"2.15","text":"And this was a patient\nwith prostate cancer"},"2864.00":{"start":"2864","dur":"3.58","text":"who did very poorly with\nall the standard treatments."},"2867.58":{"start":"2867.58","dur":"3.13","text":"And so we went ahead and\nwe biopsied his cancer"},"2870.71":{"start":"2870.71","dur":"2.9","text":"after it had become metastatic\nand had spread to other sites."},"2873.61":{"start":"2873.61","dur":"1.85","text":"And then we did the\ntesting, and what"},"2875.46":{"start":"2875.46","dur":"2.11","text":"was notable about his\ntumor is that he actually"},"2877.57":{"start":"2877.57","dur":"4.13","text":"had 29 mutations\nidentified by the assay."},"2881.70":{"start":"2881.7","dur":"1.84","text":"And that&#39;s surprising\nin prostate cancer,"},"2883.54":{"start":"2883.54","dur":"3.12","text":"because most prostate cancers\nonly have a few mutations."},"2886.66":{"start":"2886.66","dur":"3.16","text":"So prostate cancer&#39;s known\nfor a very low mutation rate."},"2889.82":{"start":"2889.82","dur":"2.89","text":"But this guy had a very\nhigh mutation rate tumor."},"2892.71":{"start":"2892.71","dur":"3.551","text":"And he actually had two\ngenes that were mutated."},"2896.26":{"start":"2896.261","dur":"1.249","text":"The red bars are a little off."},"2897.51":{"start":"2897.51","dur":"2.62","text":"One&#39;s called MLH1, the\nother&#39;s called MSH2."},"2900.13":{"start":"2900.13","dur":"1.83","text":"And these were both\ntruncating mutations."},"2901.96":{"start":"2901.96","dur":"1.916","text":"And what&#39;s interesting\nabout these genes"},"2903.88":{"start":"2903.876","dur":"1.874","text":"is that when you get\nmutations in these genes"},"2905.75":{"start":"2905.75","dur":"2.34","text":"in the normal cells, you\nhave a condition called"},"2908.09":{"start":"2908.09","dur":"2.74","text":"Lynch syndrome, which\nleads to colorectal"},"2910.83":{"start":"2910.83","dur":"1.29","text":"cancers, endometrial cancers."},"2912.12":{"start":"2912.12","dur":"3.01","text":"Not typically prostate\ncancers, but you"},"2915.13":{"start":"2915.13","dur":"2.51","text":"get these hypermutated tumors."},"2917.64":{"start":"2917.64","dur":"3.02","text":"And what we&#39;ve learned is that\nif you test immunotherapies--"},"2920.66":{"start":"2920.66","dur":"3.78","text":"these are a new class of drugs\nthat harness the immune system"},"2924.44":{"start":"2924.44","dur":"3.82","text":"to attack the cancer-- these\ntype of hypermutated tumors"},"2928.26":{"start":"2928.26","dur":"2.58","text":"are more likely to\nrespond than tumors"},"2930.84":{"start":"2930.84","dur":"1.15","text":"that have fewer mutations."},"2931.99":{"start":"2931.99","dur":"1.75","text":"And that&#39;s probably\ndue to the fact"},"2933.74":{"start":"2933.74","dur":"3.37","text":"that these hypermutated\ntumors are expressing"},"2937.11":{"start":"2937.11","dur":"3.15","text":"proteins that are seen by the\nimmune system as being foreign."},"2940.26":{"start":"2940.26","dur":"2.51","text":"They&#39;re not self, they&#39;re\nnot the normal proteins"},"2942.77":{"start":"2942.77","dur":"1.14","text":"for that individual."},"2943.91":{"start":"2943.91","dur":"2.57","text":"They&#39;ve got a slight change\nand so they&#39;re seen as foreign"},"2946.48":{"start":"2946.48","dur":"3.05","text":"and it&#39;s easier to stimulate the\nimmune system to attack them."},"2949.53":{"start":"2949.53","dur":"2.04","text":"So we actually\nhave a basket study"},"2951.57":{"start":"2951.57","dur":"1.83","text":"where you can have\nany type of cancer."},"2953.40":{"start":"2953.4","dur":"3.16","text":"If you have one of these\ntype of hypermutated tumors,"},"2956.56":{"start":"2956.56","dur":"2.77","text":"this basket study\ndesign provides access"},"2959.33":{"start":"2959.33","dur":"1.52","text":"to this type of immunotherapy."},"2960.85":{"start":"2960.85","dur":"2.75","text":"In particular for this trial,\na drug called MEDI4736."},"2963.60":{"start":"2963.6","dur":"4.92","text":"This is a drug that binds to\na protein called PD1, which"},"2968.52":{"start":"2968.52","dur":"2.87","text":"leads to a checkpoint\neffect and a stimulation"},"2971.39":{"start":"2971.39","dur":"2.01","text":"of the immune system\nto fight the cancer."},"2973.40":{"start":"2973.4","dur":"2.33","text":"And I can say that this\npatient here is actually"},"2975.73":{"start":"2975.73","dur":"3.04","text":"seeing early benefit\nwith this anti PD1"},"2978.77":{"start":"2978.77","dur":"4.58","text":"therapy with this\nhypermutated prostate cancer."},"2983.35":{"start":"2983.35","dur":"1.5","text":"These type of\nhypermutated tumors"},"2984.85":{"start":"2984.85","dur":"2.59","text":"were not something we saw\nwhen we did a retrospective"},"2987.44":{"start":"2987.44","dur":"1.89","text":"analysis of early tumors."},"2989.33":{"start":"2989.33","dur":"2.19","text":"But notably, we&#39;ve found\nalready about five or six"},"2991.52":{"start":"2991.52","dur":"3.04","text":"of these patients out\nof the first 150 or so"},"2994.56":{"start":"2994.56","dur":"2.94","text":"of the prostate cancers that\nwe&#39;ve done perspectively"},"2997.50":{"start":"2997.5","dur":"0.94","text":"at Sloan Kettering."},"2998.44":{"start":"2998.44","dur":"2.08","text":"And it&#39;s possible that\nthese hypermutated tumors"},"3000.52":{"start":"3000.52","dur":"3.6","text":"are overrepresented in those\nadvanced metastatic patients"},"3004.12":{"start":"3004.12","dur":"1.725","text":"because these\nhypermutated tumors are"},"3005.85":{"start":"3005.845","dur":"1.875","text":"less likely to respond\nthe standard treatment"},"3007.72":{"start":"3007.72","dur":"2.91","text":"and more likely to recur and\nprogress to metastatic disease."},"3010.63":{"start":"3010.63","dur":"3.06","text":"So again, figuring\nout in the end what"},"3013.69":{"start":"3013.69","dur":"2.69","text":"is driving an individual\npatient&#39;s tumor,"},"3016.38":{"start":"3016.38","dur":"3.39","text":"we&#39;re hoping to use that\ninformation to really guide"},"3019.77":{"start":"3019.77","dur":"1.56","text":"the treatment of patients."},"3021.33":{"start":"3021.33","dur":"3.75","text":"Just one more point and\nthen I&#39;ll finish up."},"3025.08":{"start":"3025.08","dur":"2.316","text":"This is this company\nthat I mentioned"},"3027.40":{"start":"3027.396","dur":"1.624","text":"that&#39;s been doing\nthis type of testing."},"3029.02":{"start":"3029.02","dur":"3.65","text":"This was a report that was sent\nto me from a patient at Johns"},"3032.67":{"start":"3032.67","dur":"4.2","text":"Hopkins asking if they could\nbe on this ERBB2 basket study."},"3036.87":{"start":"3036.87","dur":"1.83","text":"And they had a\nERBB2 mutation, they"},"3038.70":{"start":"3038.7","dur":"2.31","text":"had an S310F ERBB2 mutation."},"3041.01":{"start":"3041.01","dur":"3.41","text":"But there was this\nnote on the report that"},"3044.42":{"start":"3044.42","dur":"2.18","text":"was what&#39;s called subclonal."},"3046.60":{"start":"3046.6","dur":"2.63","text":"And so what that means\nis that it&#39;s likely"},"3049.23":{"start":"3049.23","dur":"2.37","text":"at least you can\ninfer informatically"},"3051.60":{"start":"3051.6","dur":"3.25","text":"that this mutation is not likely\npresent in every single cancer"},"3054.85":{"start":"3054.85","dur":"0.5","text":"cell."},"3055.35":{"start":"3055.35","dur":"3.56","text":"And so to just show you from\nour data what that means,"},"3058.91":{"start":"3058.91","dur":"1.6","text":"here&#39;s a patient\nwith breast cancer"},"3060.51":{"start":"3060.51","dur":"2.45","text":"who has an L755S mutation."},"3062.96":{"start":"3062.96","dur":"1.68","text":"The allele frequency\nhere is the number"},"3064.64":{"start":"3064.64","dur":"3.07","text":"of reads in the tumor\nthat have the mutation"},"3067.71":{"start":"3067.71","dur":"1.025","text":"versus the normal reads."},"3068.74":{"start":"3068.735","dur":"2.815","text":"And we never see this as 100%,\nbecause typically you only"},"3071.55":{"start":"3071.55","dur":"1.84","text":"mutate one copy of the gene."},"3073.39":{"start":"3073.39","dur":"1.97","text":"And also there&#39;s this\nstromal contamination"},"3075.36":{"start":"3075.36","dur":"2.16","text":"of the normal cells,\nwhich are obviously"},"3077.52":{"start":"3077.52","dur":"1.56","text":"normal for the mutation."},"3079.08":{"start":"3079.08","dur":"2.81","text":"But what&#39;s notable, it&#39;s 58%\nhere, 20 something percent"},"3081.89":{"start":"3081.89","dur":"1.38","text":"for the other two mutations."},"3083.27":{"start":"3083.27","dur":"2.08","text":"This is probably a\nmutant where there&#39;s"},"3085.35":{"start":"3085.35","dur":"2.03","text":"two copies of the\nmutation for ERBB2"},"3087.38":{"start":"3087.38","dur":"2.155","text":"and one copy for\nthese other two genes."},"3089.54":{"start":"3089.535","dur":"1.541","text":"If I look at this\nother patient, this"},"3091.08":{"start":"3091.076","dur":"1.784","text":"is a patient with\nbladder cancer where"},"3092.86":{"start":"3092.86","dur":"4.29","text":"can see this P53 mutation&#39;s\nin 57% of the reads,"},"3097.15":{"start":"3097.15","dur":"3.34","text":"the TSE1 is in 61% of the\nreads, but the ERBB2 mutation&#39;s"},"3100.49":{"start":"3100.49","dur":"1.18","text":"only in 3% of the reads."},"3101.67":{"start":"3101.67","dur":"2.18","text":"And the way you can\nstatistically get that"},"3103.85":{"start":"3103.85","dur":"3.33","text":"is if the ERBB2 mutation is\njust in some of the cancer cells"},"3107.18":{"start":"3107.18","dur":"1.48","text":"and not in all the cancer cells."},"3108.66":{"start":"3108.66","dur":"3.43","text":"And one could imagine that\nif the mutation that we&#39;re"},"3112.09":{"start":"3112.09","dur":"2.51","text":"targeting is not in\nevery single cancer cell,"},"3114.60":{"start":"3114.6","dur":"2.87","text":"when we give the drug, the cells\nthat don&#39;t have the mutation"},"3117.47":{"start":"3117.47","dur":"3.16","text":"are probably going to quickly\ngrow out and become resistant."},"3120.63":{"start":"3120.63","dur":"3.11","text":"And this type of what we\ncall clonality analysis"},"3123.74":{"start":"3123.74","dur":"3.07","text":"is very difficult to do when you\nhave limited amounts of data."},"3126.81":{"start":"3126.81","dur":"3.26","text":"So if we only have a\nsmall list of mutations"},"3130.07":{"start":"3130.07","dur":"2.23","text":"because we&#39;re only\nsequencing a few genes,"},"3132.30":{"start":"3132.3","dur":"1.36","text":"it&#39;s very difficult to do this."},"3133.66":{"start":"3133.66","dur":"2.87","text":"But if we do whole exome\nor whole genome sequencing,"},"3136.53":{"start":"3136.53","dur":"3.03","text":"we can actually define\nthis clonality much better."},"3139.56":{"start":"3139.56","dur":"2.47","text":"It still takes a huge amount\nof computational resource"},"3142.03":{"start":"3142.03","dur":"1.66","text":"to do this type of analysis."},"3143.69":{"start":"3143.69","dur":"2.04","text":"But as this technology\ngets better,"},"3145.73":{"start":"3145.73","dur":"1.75","text":"this is the type of\ndata we&#39;re going to be"},"3147.48":{"start":"3147.48","dur":"1.35","text":"getting for every patient."},"3148.83":{"start":"3148.83","dur":"1.97","text":"And it&#39;s not going\nto simply be do"},"3150.80":{"start":"3150.8","dur":"2.72","text":"you have the mutation as a\nbinary variable, yes or no,"},"3153.52":{"start":"3153.52","dur":"3.41","text":"but is that mutation what we\ncall an early truncal mutation?"},"3156.93":{"start":"3156.93","dur":"4.7","text":"Is it present in all cells\nor is present in just some?"},"3161.63":{"start":"3161.63","dur":"2.88","text":"This is an interesting\npatient where we have"},"3164.51":{"start":"3164.51","dur":"1.93","text":"four tumors that we sequenced."},"3166.44":{"start":"3166.44","dur":"2.47","text":"And this is how the\ncBioPortal shows that."},"3168.91":{"start":"3168.91","dur":"2.48","text":"And you can see for\nthese four genes,"},"3171.39":{"start":"3171.39","dur":"3.04","text":"these four mutations were\nfound in all four tumors."},"3174.43":{"start":"3174.43","dur":"2.95","text":"But you could see the ERBB2\nmutation was just in tumor one."},"3177.38":{"start":"3177.38","dur":"2.465","text":"This PIK3CA mutation was\njust in two and four."},"3179.85":{"start":"3179.845","dur":"2.475","text":"We actually have drugs\nagainst both of these targets."},"3182.32":{"start":"3182.32","dur":"2.48","text":"The EGFR mutation was\nonly in tumor three."},"3184.80":{"start":"3184.8","dur":"2.07","text":"The P10 only in tumor two."},"3186.87":{"start":"3186.87","dur":"2.11","text":"So these are all\ndruggable mutations,"},"3188.98":{"start":"3188.98","dur":"2.95","text":"but they&#39;re not in\nevery single tumor cell."},"3191.93":{"start":"3191.93","dur":"2.64","text":"And so this is an additional\nlevel of complexity"},"3194.57":{"start":"3194.57","dur":"2","text":"that is going to\nmake this difficult."},"3196.57":{"start":"3196.57","dur":"2","text":"And is really going to\nrequire to eventually use"},"3198.57":{"start":"3198.57","dur":"4.14","text":"combinations of these inhibitors\nto really see maximal effect."},"3202.71":{"start":"3202.71","dur":"1.64","text":"So I&#39;m just going\nto leave it there"},"3204.35":{"start":"3204.35","dur":"2.51","text":"and just acknowledge\na number of people."},"3206.86":{"start":"3206.86","dur":"2.5","text":"I really want to acknowledge\nGopa Iyer, a very talented-- he"},"3209.36":{"start":"3209.36","dur":"2.834","text":"was initially a postdoc fellow,\nnow junior faculty member who"},"3212.19":{"start":"3212.194","dur":"1.666","text":"was in my lab and\nreally started with me"},"3213.86":{"start":"3213.86","dur":"2.364","text":"this extraordinary\nresponder initiative."},"3216.22":{"start":"3216.224","dur":"2.416","text":"The center I run, which is the\nKravis Center for Molecular"},"3218.64":{"start":"3218.64","dur":"2","text":"Oncology at Sloan\nKettering, I&#39;ve"},"3220.64":{"start":"3220.64","dur":"1.74","text":"got three associate directors."},"3222.38":{"start":"3222.38","dur":"3.51","text":"One, Mike Berger, who developed\nthis impact assay and really"},"3225.89":{"start":"3225.89","dur":"1.67","text":"deserves a lot of\ncredit for that."},"3227.56":{"start":"3227.56","dur":"2.62","text":"Another, Agnes Viale, who runs\nour operational sequencing"},"3230.18":{"start":"3230.18","dur":"0.71","text":"core."},"3230.89":{"start":"3230.89","dur":"1.583","text":"And then Barry Taylor,\nwho we actually"},"3232.47":{"start":"3232.473","dur":"2.297","text":"recruited back from\nUCSF just recently"},"3234.77":{"start":"3234.77","dur":"3.08","text":"to head what we call\ncomputational oncology."},"3237.85":{"start":"3237.85","dur":"2.42","text":"And this is really a new\nfield that didn&#39;t exist"},"3240.27":{"start":"3240.27","dur":"1.91","text":"before the last couple years."},"3242.18":{"start":"3242.18","dur":"2.13","text":"And so what&#39;s\ncomputational oncology?"},"3244.31":{"start":"3244.31","dur":"4.08","text":"These are people who use\ncomputational tools to answer"},"3248.39":{"start":"3248.39","dur":"1.64","text":"clinical and biologic questions."},"3250.03":{"start":"3250.03","dur":"2.56","text":"So we now have a whole\ngroup of scientists"},"3252.59":{"start":"3252.59","dur":"4.15","text":"that that&#39;s what they&#39;re\ngoing to be identified as,"},"3256.74":{"start":"3256.74","dur":"2.394","text":"as computational biologists\nor computational oncologists."},"3259.13":{"start":"3259.134","dur":"1.666","text":"And then just note\nseveral other people."},"3260.80":{"start":"3260.8","dur":"2.575","text":"Marc Ladanyi, who runs our\nclinical sequencing lab"},"3263.38":{"start":"3263.375","dur":"1.465","text":"with Maria Arcila."},"3264.84":{"start":"3264.84","dur":"2.75","text":"Dave Hyman, who runs a lot of\nthese basket studies with me,"},"3267.59":{"start":"3267.59","dur":"2.209","text":"and Jose Baselga, who&#39;s\nour physician in chief,"},"3269.80":{"start":"3269.799","dur":"1.791","text":"and has really provided\na lot of leadership"},"3271.59":{"start":"3271.59","dur":"2.53","text":"to get this sequencing\neffort up and running."},"3274.12":{"start":"3274.12","dur":"2.25","text":"So thanks again\nfor the invitation."},"3276.37":{"start":"3276.37","dur":"3.13","text":"Happy to answer any questions,\neither now or formally later."},"3279.50":{"start":"3279.5","dur":"1.104","text":"So thank you."},"3280.60":{"start":"3280.604","dur":"2.485","text":"[APPLAUSE]"},"3285.08":{"start":"3285.077","dur":"2.703","text":"AUDIENCE: You showed a slide\nwhere one person had you"},"3287.78":{"start":"3287.78","dur":"2.837","text":"said, 20 some mutations\nin the prostate."},"3290.62":{"start":"3290.617","dur":"0.833","text":"DAVID B. SOLIT: Yes."},"3291.45":{"start":"3291.45","dur":"0.63","text":"This is--"},"3292.08":{"start":"3292.08","dur":"3.32","text":"AUDIENCE: And then you had a\nprevious slide further back"},"3295.40":{"start":"3295.4","dur":"4.3","text":"where you did a single tumor."},"3299.70":{"start":"3299.7","dur":"3.005","text":"And you had 19,000\nsomatic mutations."},"3304.85":{"start":"3304.845","dur":"0.875","text":"DAVID B. SOLIT: Yeah."},"3305.72":{"start":"3305.72","dur":"1.666","text":"AUDIENCE: And from\nwhat I read actually,"},"3307.39":{"start":"3307.386","dur":"8.594","text":"that&#39;s more the common\ncase versus the cancer"},"3315.98":{"start":"3315.98","dur":"2.22","text":"that you have very\nfew mutations."},"3318.20":{"start":"3318.2","dur":"2.99","text":"The common case is that\nyou have tens of thousands"},"3321.19":{"start":"3321.19","dur":"1.369","text":"of mutations in a single tumor."},"3322.56":{"start":"3322.559","dur":"1.791","text":"DAVID B. SOLIT: So let\nme just clarify this"},"3324.35":{"start":"3324.35","dur":"1.93","text":"as an issue maybe\nI wasn&#39;t clear on,"},"3326.28":{"start":"3326.28","dur":"2.73","text":"which is really differences\nin the denominator."},"3329.01":{"start":"3329.01","dur":"2.35","text":"So this assay that\nI&#39;m showing you here,"},"3331.36":{"start":"3331.36","dur":"3.15","text":"this was an assay of\njust 341 cancer genes."},"3334.51":{"start":"3334.51","dur":"2.18","text":"So this was our capture\nbased approach where we just"},"3336.69":{"start":"3336.69","dur":"1.99","text":"pull down parts of the genome."},"3338.68":{"start":"3338.68","dur":"2.546","text":"And when we do that, the\nscale&#39;s obviously different"},"3341.23":{"start":"3341.226","dur":"2.374","text":"because we&#39;re only sequencing\na small part of the genome."},"3343.60":{"start":"3343.6","dur":"1.79","text":"We&#39;re sequencing the\npart of the genome"},"3345.39":{"start":"3345.39","dur":"2.41","text":"with all the known\ncancer genes in it,"},"3347.80":{"start":"3347.8","dur":"4.13","text":"but it&#39;s a very small\nfraction of the total genome."},"3351.93":{"start":"3351.93","dur":"2.94","text":"And so this is a lot of\nmutations for sequencing"},"3354.87":{"start":"3354.87","dur":"1.149","text":"just that small part."},"3356.02":{"start":"3356.019","dur":"0.541","text":"AUDIENCE: OK."},"3356.56":{"start":"3356.56","dur":"1.3","text":"DAVID B. SOLIT:\nThe 19,000 referred"},"3357.86":{"start":"3357.86","dur":"1.409","text":"to sequencing the entire genome."},"3359.27":{"start":"3359.269","dur":"0.666","text":"AUDIENCE: Right."},"3359.94":{"start":"3359.935","dur":"1.705","text":"DAVID B. SOLIT: And\nwithin that 19,000,"},"3361.64":{"start":"3361.64","dur":"3.36","text":"that patient probably had\nabout 140 coding mutations."},"3365.00":{"start":"3365","dur":"2.441","text":"And if you actually\njust ran IMPACT,"},"3367.44":{"start":"3367.441","dur":"2.249","text":"you probably only would have\nfound about eight or nine"},"3369.69":{"start":"3369.69","dur":"0.64","text":"mutations."},"3370.33":{"start":"3370.33","dur":"3.59","text":"So it&#39;s really a difference\nof what fraction of the genome"},"3373.92":{"start":"3373.92","dur":"1.1","text":"are we sequencing?"},"3375.02":{"start":"3375.02","dur":"2.125","text":"Those numbers are going to\nbe very different, yeah."},"3377.15":{"start":"3377.145","dur":"3.095","text":"AUDIENCE: So maybe the premise\nof my question is wrong."},"3380.24":{"start":"3380.24","dur":"4.762","text":"But my question was if\nyou&#39;ve got so many--"},"3385.00":{"start":"3385.002","dur":"2.208","text":"you kind of boiled it down\nto a much smaller number--"},"3387.21":{"start":"3387.21","dur":"4.09","text":"but if you&#39;ve got 19,000 somatic\nmutations, how many, if you"},"3391.30":{"start":"3391.3","dur":"4.04","text":"were to look at so-called\nnormal cells in a normal person,"},"3395.34":{"start":"3395.34","dur":"2.99","text":"a typical assay, how\nmany mutations would you"},"3398.33":{"start":"3398.33","dur":"0.995","text":"find in normal cells?"},"3399.33":{"start":"3399.325","dur":"1.645","text":"DAVID B. SOLIT: So\nthe normal cells"},"3400.97":{"start":"3400.97","dur":"2.31","text":"have no mutations by\ndefinition, because we&#39;re"},"3403.28":{"start":"3403.28","dur":"3.6","text":"using that as the reference\nfor each individual patient."},"3406.88":{"start":"3406.88","dur":"3.99","text":"So there is the normal\ncoding sequence,"},"3410.87":{"start":"3410.87","dur":"6.07","text":"which is really created by an\namalgamation of many people."},"3416.94":{"start":"3416.94","dur":"2.99","text":"And then there are variations\nfrom individual to individual."},"3419.93":{"start":"3419.93","dur":"3.13","text":"So because there&#39;s these\npolymorphisms, or differences"},"3423.06":{"start":"3423.06","dur":"2.75","text":"in the genome\nbetween individuals,"},"3425.81":{"start":"3425.81","dur":"3.58","text":"we actually don&#39;t want to\nuse this reference sequence"},"3429.39":{"start":"3429.39","dur":"2.93","text":"for the actual calling of\na mutation that&#39;s somatic."},"3432.32":{"start":"3432.32","dur":"4","text":"We want to actually compare\nthis individual patient&#39;s"},"3436.32":{"start":"3436.32","dur":"3.73","text":"normal to this tumor\nand actually then"},"3440.05":{"start":"3440.05","dur":"0.99","text":"digitally subtract it."},"3441.04":{"start":"3441.04","dur":"1.86","text":"If you don&#39;t do\nthat, you&#39;ll end up"},"3442.90":{"start":"3442.9","dur":"3.1","text":"with thousands of\nadditional polymorphisms"},"3446.00":{"start":"3446","dur":"1.89","text":"between any individual\nand actually"},"3447.89":{"start":"3447.89","dur":"1.16","text":"the reference sequence."},"3449.05":{"start":"3449.05","dur":"3","text":"Now when we sequence the normal,\nwe don&#39;t sequence one cell."},"3452.05":{"start":"3452.05","dur":"3.76","text":"We sequence what is DNA\nextracted out of thousands"},"3455.81":{"start":"3455.81","dur":"2.4","text":"or tens of thousands of cells."},"3458.21":{"start":"3458.21","dur":"4.032","text":"And so if you actually sequenced\njust one individual cell,"},"3462.24":{"start":"3462.242","dur":"1.708","text":"you took hundreds of\nthem, you might even"},"3463.95":{"start":"3463.95","dur":"1.63","text":"see some mutations\nthat are slightly"},"3465.58":{"start":"3465.58","dur":"2.241","text":"different from this\ncell to that cell."},"3467.82":{"start":"3467.821","dur":"1.749","text":"But we don&#39;t pick it\nup with this approach"},"3469.57":{"start":"3469.57","dur":"2.656","text":"because we&#39;re averaging that\nout and then that detail&#39;s lost."},"3472.23":{"start":"3472.226","dur":"2.374","text":"AUDIENCE: But it&#39;s radically\ndifferent in a cancer tumor,"},"3474.60":{"start":"3474.6","dur":"0.21","text":"right?"},"3474.81":{"start":"3474.81","dur":"0.49","text":"DAVID B. SOLIT:\nBut you know, yeah."},"3475.30":{"start":"3475.3","dur":"1.63","text":"AUDIENCE: So a cancer\ntumor, radically more."},"3476.93":{"start":"3476.93","dur":"0.49","text":"DAVID B. SOLIT:\nDramatically higher, yeah."},"3477.42":{"start":"3477.42","dur":"1.51","text":"AUDIENCE: So how\ndo you explain that"},"3478.93":{"start":"3478.93","dur":"5.31","text":"on a fundamental biological when\nyou&#39;re looking at first causes?"},"3484.24":{"start":"3484.24","dur":"1.482","text":"You would think,\nfor example, or I"},"3485.72":{"start":"3485.722","dur":"1.708","text":"would think-- just\nkind of a lay person--"},"3487.43":{"start":"3487.43","dur":"4.87","text":"that if you imagine\nthat cancer is caused"},"3492.30":{"start":"3492.3","dur":"2.55","text":"by some initial\nsomatic mutation,"},"3494.85":{"start":"3494.85","dur":"4.004","text":"why does that single mutation\nnot dominate and survive"},"3498.85":{"start":"3498.854","dur":"0.916","text":"throughout the cancer?"},"3499.77":{"start":"3499.77","dur":"2.13","text":"So why do you have\ntens of thousands?"},"3501.90":{"start":"3501.9","dur":"2.84","text":"This is a real mystery."},"3504.74":{"start":"3504.74","dur":"2.14","text":"And it seems like a real\nproblem to this approach."},"3506.88":{"start":"3506.88","dur":"2.64","text":"Because if you&#39;ve got\ntens of thousands--"},"3509.52":{"start":"3509.52","dur":"2.73","text":"and some places I&#39;ve read\nthey say hundreds of thousands"},"3512.25":{"start":"3512.25","dur":"1.616","text":"of mutations in a single tumor--"},"3513.87":{"start":"3513.866","dur":"0.874","text":"DAVID B. SOLIT: Yeah."},"3514.74":{"start":"3514.74","dur":"0.3","text":"So--"},"3515.04":{"start":"3515.04","dur":"0.852","text":"AUDIENCE: Then how?"},"3515.89":{"start":"3515.892","dur":"2.458","text":"DAVID B. SOLIT: So we actually\nhave a lot of sense for this"},"3518.35":{"start":"3518.35","dur":"4","text":"now with the Tumor Cancer\nGenome Atlas that&#39;s been done."},"3522.35":{"start":"3522.35","dur":"2.77","text":"There&#39;s very well\ncharacterized whole exome data."},"3525.12":{"start":"3525.12","dur":"1.46","text":"So not a lot of\nwhole genome data,"},"3526.58":{"start":"3526.58","dur":"3.86","text":"but whole exome data, showing\nthat, for example in melanomas,"},"3530.44":{"start":"3530.44","dur":"3.61","text":"it&#39;s not uncommon to have\n3,000 or so exomic mutations."},"3534.05":{"start":"3534.05","dur":"3.87","text":"And that&#39;s the tumor that has\nthe highest mutation rate."},"3537.92":{"start":"3537.92","dur":"3.62","text":"There are many pediatric\ncancers-- lymphomas"},"3541.54":{"start":"3541.54","dur":"3.38","text":"and leukemias-- that have an\nexceedingly low mutation rate."},"3544.92":{"start":"3544.92","dur":"2.63","text":"And some of it has to do with\nthe pathogenesis of the cancer."},"3547.55":{"start":"3547.55","dur":"1.63","text":"So what was the\ntoxin that caused it?"},"3549.18":{"start":"3549.18","dur":"4.63","text":"So ultraviolet light is what&#39;s\ncausing these melanomas."},"3553.81":{"start":"3553.81","dur":"2.17","text":"And actually many\nof the mutations"},"3555.98":{"start":"3555.98","dur":"3.66","text":"are ones that are caused by\nultraviolet light induced"},"3559.64":{"start":"3559.64","dur":"0.57","text":"changes."},"3560.21":{"start":"3560.21","dur":"2.1","text":"Whereas in lung\ncancers, which is also"},"3562.31":{"start":"3562.31","dur":"2.87","text":"another hypermutated tumor,\nthe mutation spectrum"},"3565.18":{"start":"3565.18","dur":"2.66","text":"is a different type\nof amino base pair"},"3567.84":{"start":"3567.84","dur":"6.9","text":"change than what you see in a\nultraviolet induced melanoma."},"3574.74":{"start":"3574.74","dur":"2.78","text":"So many of these are passengers."},"3577.52":{"start":"3577.52","dur":"1.61","text":"How many are actually\ndrivers, which"},"3579.13":{"start":"3579.13","dur":"2.166","text":"make the difference between\na driver and a passenger"},"3581.30":{"start":"3581.296","dur":"2.024","text":"is a driver really is\nhaving a functional"},"3583.32":{"start":"3583.32","dur":"3.55","text":"effect in driving the\ncancer pathogenesis,"},"3586.87":{"start":"3586.87","dur":"2.06","text":"we really don&#39;t\nknow in large part."},"3588.93":{"start":"3588.93","dur":"2.54","text":"The presumption is the\nvast majority of them"},"3591.47":{"start":"3591.47","dur":"2.09","text":"are passengers, they&#39;re\nnot doing anything."},"3593.56":{"start":"3593.56","dur":"2.274","text":"But why are they there?"},"3595.83":{"start":"3595.834","dur":"1.416","text":"They&#39;re there\nbecause there&#39;s just"},"3597.25":{"start":"3597.25","dur":"3.59","text":"a stochastic randomness to\nwhere these mutations occur"},"3600.84":{"start":"3600.84","dur":"1.04","text":"in some ways."},"3601.88":{"start":"3601.88","dur":"2.88","text":"And unless you hit on\nsomething that actually"},"3604.76":{"start":"3604.76","dur":"4.199","text":"is presenting a\nsurvival advantage,"},"3608.96":{"start":"3608.959","dur":"1.041","text":"it doesn&#39;t really matter."},"3610.00":{"start":"3610","dur":"2.81","text":"So these mutations are\naccumulating in a stem cell,"},"3612.81":{"start":"3612.81","dur":"2.94","text":"and what happens is you\nget an early hit which"},"3615.75":{"start":"3615.75","dur":"2.79","text":"maybe makes a cell\nproliferate a little bit more"},"3618.54":{"start":"3618.54","dur":"1.22","text":"quickly than normal."},"3619.76":{"start":"3619.76","dur":"2.65","text":"So that cell starts to\nreplace the average population"},"3622.41":{"start":"3622.41","dur":"1.11","text":"of the normal cells."},"3623.52":{"start":"3623.52","dur":"2.85","text":"But then in that, you get\na lot of random mutations"},"3626.37":{"start":"3626.37","dur":"1.241","text":"that are not doing anything."},"3627.61":{"start":"3627.611","dur":"1.999","text":"But then eventually in\none of those cells that&#39;s"},"3629.61":{"start":"3629.61","dur":"2.66","text":"now built up more of\nthose random changes"},"3632.27":{"start":"3632.27","dur":"0.931","text":"you get a second hit."},"3633.20":{"start":"3633.201","dur":"0.999","text":"And then it accumulates."},"3634.20":{"start":"3634.2","dur":"2.17","text":"And then eventually\nyou can get a mutation"},"3636.37":{"start":"3636.37","dur":"4.82","text":"in a gene like MLH1 and MSH2,\nand these genes actually"},"3641.19":{"start":"3641.19","dur":"1.89","text":"are important for\nthe DNA replication."},"3643.08":{"start":"3643.08","dur":"5.49","text":"So once you get one of these\nDNA repair deficient mutations,"},"3648.57":{"start":"3648.57","dur":"2.12","text":"there&#39;s just going to\nbe a huge number of now"},"3650.69":{"start":"3650.69","dur":"3.51","text":"additional mutations\nthat are caused"},"3654.20":{"start":"3654.2","dur":"2.43","text":"because these the\nfidelity of DNA repair"},"3656.63":{"start":"3656.63","dur":"2.9","text":"or DNA reproduction is very low."},"3659.53":{"start":"3659.53","dur":"2.374","text":"And so that&#39;s part of it."},"3661.90":{"start":"3661.904","dur":"1.666","text":"I can&#39;t answer your\nquestion completely."},"3663.57":{"start":"3663.57","dur":"1.191","text":"Yeah."},"3664.76":{"start":"3664.761","dur":"1.669","text":"AUDIENCE: It sounds\nlike eventually this"},"3666.43":{"start":"3666.43","dur":"2.02","text":"is going to go towards\nif you have cancer,"},"3668.45":{"start":"3668.45","dur":"1.986","text":"you&#39;ll get a screening\nupfront and figure out"},"3670.44":{"start":"3670.436","dur":"1.374","text":"what genomic\nalterations you have"},"3671.81":{"start":"3671.81","dur":"2.93","text":"and you can match\nthem with a drug."},"3674.74":{"start":"3674.74","dur":"2.265","text":"Do you think the\nrate limiting factor"},"3677.01":{"start":"3677.005","dur":"4.245","text":"on that will be technology\nor insurance or physician"},"3681.25":{"start":"3681.25","dur":"0.602","text":"adoption?"},"3681.85":{"start":"3681.852","dur":"1.708","text":"Which one of those is\nthe biggest hurdle?"},"3683.56":{"start":"3683.56","dur":"3.66","text":"DAVID B. SOLIT: So until this\npast year, it was technology."},"3687.22":{"start":"3687.22","dur":"2.98","text":"So even if you had\nunlimited amounts of money,"},"3690.20":{"start":"3690.2","dur":"2.41","text":"you simply couldn&#39;t do this."},"3692.61":{"start":"3692.61","dur":"4.23","text":"It would take a team of\ndozens months or years"},"3696.84":{"start":"3696.84","dur":"1.83","text":"to do an individual genome."},"3698.67":{"start":"3698.67","dur":"1.45","text":"And that&#39;s just not feasible."},"3700.12":{"start":"3700.12","dur":"3.18","text":"But now my lab can do\na whole genome sequence"},"3703.30":{"start":"3703.3","dur":"2.88","text":"on any individual\nfor less than $10,000"},"3706.18":{"start":"3706.18","dur":"4.66","text":"if we spend X amount of\ntime to do the analysis."},"3710.84":{"start":"3710.84","dur":"4.29","text":"So it&#39;s getting quicker and\nit&#39;ll be turnkey more and more."},"3715.13":{"start":"3715.13","dur":"2.93","text":"So as the informatic tools,\nthe algorithms get better,"},"3718.06":{"start":"3718.06","dur":"1.92","text":"they&#39;re more automated."},"3719.98":{"start":"3719.98","dur":"2.83","text":"We actually are limited\nby computational power"},"3722.81":{"start":"3722.81","dur":"2.1","text":"at Sloan Kettering."},"3724.91":{"start":"3724.91","dur":"1.1","text":"You guys could laugh."},"3726.01":{"start":"3726.01","dur":"3.5","text":"We have 1.5 petabytes of\nmemory and that&#39;s all we got."},"3729.51":{"start":"3729.51","dur":"3.09","text":"And we&#39;ve got a cluster\nwith this many processors."},"3732.60":{"start":"3732.6","dur":"4.42","text":"And our thing is\nsome of the analysis"},"3737.02":{"start":"3737.02","dur":"1.64","text":"is waiting to get\non to the cluster."},"3738.66":{"start":"3738.66","dur":"2.39","text":"We just don&#39;t have enough\ncomputational power"},"3741.05":{"start":"3741.05","dur":"2.3","text":"to be doing more than we can."},"3743.35":{"start":"3743.35","dur":"2.59","text":"And we spent $2.5\nmillion last year"},"3745.94":{"start":"3745.94","dur":"2.12","text":"alone on computational\nresources,"},"3748.06":{"start":"3748.06","dur":"2.12","text":"and that&#39;s a lot of money\nfor a nonprofit hospital"},"3750.18":{"start":"3750.18","dur":"0.541","text":"to be paying."},"3750.72":{"start":"3750.721","dur":"3.119","text":"So right now, technology\nis still limiting."},"3753.84":{"start":"3753.84","dur":"4.24","text":"But that clearly is\ngoing to go away."},"3758.08":{"start":"3758.08","dur":"1.79","text":"The other problem\nis doctor adoption."},"3759.87":{"start":"3759.87","dur":"4.78","text":"I think even if the\ntechnology becomes completely"},"3764.65":{"start":"3764.65","dur":"4.584","text":"turnkey and inexpensive, and\neven if the insurance companies"},"3769.23":{"start":"3769.234","dur":"1.916","text":"start paying for some\ndegree-- and they&#39;re not"},"3771.15":{"start":"3771.15","dur":"1.26","text":"going to pay for whole\ngenome right away."},"3772.41":{"start":"3772.41","dur":"2.333","text":"What they&#39;re going to do is\npay for some number of genes"},"3774.74":{"start":"3774.743","dur":"1.717","text":"and then as the cost\ngoes down, they&#39;ll"},"3776.46":{"start":"3776.46","dur":"1.277","text":"pay for more and more genes."},"3777.74":{"start":"3777.737","dur":"1.583","text":"And then maybe\neventually it&#39;s cheaper"},"3779.32":{"start":"3779.32","dur":"1.93","text":"to just do the whole\ngenome in everyone."},"3781.25":{"start":"3781.25","dur":"2.05","text":"But the other\ndownside of this is"},"3783.30":{"start":"3783.3","dur":"1.72","text":"doing this type of\nsequencing somewhat"},"3785.02":{"start":"3785.02","dur":"2.49","text":"opens up a Pandora&#39;s box."},"3787.51":{"start":"3787.51","dur":"4.88","text":"And that&#39;s because we all have\nprobably 10 to 20, if not more,"},"3792.39":{"start":"3792.39","dur":"2.99","text":"polymorphisms in our\nnormal cells that"},"3795.38":{"start":"3795.38","dur":"1.94","text":"put us at risk for something."},"3797.32":{"start":"3797.32","dur":"1.6","text":"And it&#39;s not\nsomething that we all"},"3798.92":{"start":"3798.92","dur":"2.14","text":"want to worry about\nfor our entire life."},"3801.06":{"start":"3801.06","dur":"3.16","text":"So just to give you a\nquick scenario here,"},"3804.22":{"start":"3804.22","dur":"3.76","text":"we run our genetic test here\nfor a patient with cancer"},"3807.98":{"start":"3807.98","dur":"2.1","text":"and the patient&#39;s cured."},"3810.08":{"start":"3810.08","dur":"2.542","text":"One of the genes in our\nassay is called PARK2."},"3812.62":{"start":"3812.622","dur":"1.958","text":"And this is a gene that&#39;s\nimportant for cancer."},"3814.58":{"start":"3814.58","dur":"1.09","text":"It&#39;s a tumor suppressor."},"3815.67":{"start":"3815.67","dur":"2.82","text":"It&#39;s a gene that was shown to be\na tumor suppressor in a paper I"},"3818.49":{"start":"3818.49","dur":"2.36","text":"published with a colleague\nof mine, Tim Chan,"},"3820.85":{"start":"3820.85","dur":"1.32","text":"just a few years ago."},"3822.17":{"start":"3822.17","dur":"2.69","text":"But the reason that the\ngene is called PARK2"},"3824.86":{"start":"3824.86","dur":"2.51","text":"is because it&#39;s found\nin the germ line,"},"3827.37":{"start":"3827.37","dur":"2.79","text":"so in the normal cells,\nof patients who have early"},"3830.16":{"start":"3830.16","dur":"2.19","text":"onset Parkinson&#39;s disease."},"3832.35":{"start":"3832.35","dur":"2.8","text":"And so imagine the scenario\nof a patient coming in,"},"3835.15":{"start":"3835.15","dur":"3.31","text":"they get sequenced, we use the\nsequencing data to tell them"},"3838.46":{"start":"3838.46","dur":"2.2","text":"how best to treat their cancer."},"3840.66":{"start":"3840.66","dur":"3.76","text":"And then the oncologist\nsays, oh by the way,"},"3844.42":{"start":"3844.42","dur":"2.89","text":"you have a germ line\nmutation of PARK2"},"3847.31":{"start":"3847.31","dur":"3.29","text":"and you have an 80% chance of\ngetting Parkinson&#39;s disease"},"3850.60":{"start":"3850.6","dur":"3.08","text":"by the age of 50, and we have\nnothing we can do about that."},"3853.68":{"start":"3853.68","dur":"3.84","text":"So did you want to\nknow that information?"},"3857.52":{"start":"3857.52","dur":"3.65","text":"And as we find more and more\nof those susceptibility genes,"},"3861.17":{"start":"3861.17","dur":"2.18","text":"ones that maybe are less\npenetrant, meaning they&#39;re"},"3863.35":{"start":"3863.35","dur":"4.777","text":"less of a phenotype\nor less dominant,"},"3868.13":{"start":"3868.127","dur":"1.583","text":"we&#39;re all going to\nhave some of these."},"3869.71":{"start":"3869.71","dur":"4.41","text":"And is this going to create\nso much anxiety in all of us"},"3874.12":{"start":"3874.12","dur":"1.86","text":"that some people\nare going to have"},"3875.98":{"start":"3875.98","dur":"1.71","text":"a hard time dealing with that?"},"3877.69":{"start":"3877.69","dur":"3.42","text":"So there is really a huge\namount of worry and concern"},"3881.11":{"start":"3881.11","dur":"2.69","text":"in the community as\nwe&#39;re doing this testing"},"3883.80":{"start":"3883.8","dur":"2.3","text":"to make sure that when\nwe look at the germ line"},"3886.10":{"start":"3886.1","dur":"3.69","text":"data in particular, that we&#39;re\nvery careful in how we counsel"},"3889.79":{"start":"3889.79","dur":"1.88","text":"the patients as to\nwhat this means,"},"3891.67":{"start":"3891.67","dur":"3.12","text":"and that we don&#39;t return a lot\nof information that is this"},"3894.79":{"start":"3894.79","dur":"2.87","text":"is a change in your germ line in\na gene that could be important"},"3897.66":{"start":"3897.66","dur":"0.97","text":"but we don&#39;t know what it means."},"3898.63":{"start":"3898.63","dur":"1.666","text":"And then patients are\nworrying about it."},"3900.30":{"start":"3900.296","dur":"2.484","text":"So that&#39;s going to slow\nphysician adoption of this"},"3902.78":{"start":"3902.78","dur":"1.43","text":"a little bit."},"3904.21":{"start":"3904.21","dur":"2.35","text":"But eventually, I think\nall of us in the field"},"3906.56":{"start":"3906.56","dur":"3.206","text":"think eventually 10 years\ndown the line, 15 years down"},"3909.77":{"start":"3909.766","dur":"3.044","text":"the line, you&#39;re just going\nto come in and in a day,"},"3912.81":{"start":"3912.81","dur":"1.57","text":"here&#39;s your tumor sequence."},"3914.38":{"start":"3914.38","dur":"1.93","text":"And then we&#39;re going to match\nyou up to certain therapies"},"3916.31":{"start":"3916.31","dur":"0.74","text":"based upon that."},"3917.05":{"start":"3917.05","dur":"1.74","text":"But getting there\nis going to require"},"3918.79":{"start":"3918.79","dur":"2.47","text":"some significant\ntechnologic improvements."},"3921.26":{"start":"3921.26","dur":"2.03","text":"Definitely better\ncomputational algorithms"},"3923.29":{"start":"3923.29","dur":"2.06","text":"for the analysis,\nbetter databases"},"3925.35":{"start":"3925.35","dur":"3.19","text":"of what all these mutations\nmean, not just somatically"},"3928.54":{"start":"3928.54","dur":"3.849","text":"but also in the germ line\nalterations, and then also"},"3932.39":{"start":"3932.389","dur":"1.541","text":"better biologic\nunderstanding of what"},"3933.93":{"start":"3933.93","dur":"1.7","text":"they mean so we\ncan counsel people"},"3935.63":{"start":"3935.63","dur":"2.59","text":"that they don&#39;t worry about\nthings that are not important."},"3938.22":{"start":"3938.22","dur":"4.212","text":"And then probably even\nnew laws, because if you"},"3942.43":{"start":"3942.432","dur":"2.458","text":"tell that patient that they\nhave that PARK2 mutation, maybe"},"3944.89":{"start":"3944.89","dur":"1.458","text":"they can&#39;t get life\ninsurance, they"},"3946.35":{"start":"3946.348","dur":"1.602","text":"can&#39;t get health insurance."},"3947.95":{"start":"3947.95","dur":"1.8","text":"Their family may have\nthe same mutation"},"3949.75":{"start":"3949.75","dur":"2.72","text":"and maybe can&#39;t get health\ninsurance or life insurance."},"3952.47":{"start":"3952.47","dur":"2.352","text":"So this test is maybe\nnot just affecting you,"},"3954.82":{"start":"3954.822","dur":"1.458","text":"it&#39;s affecting your\nfamily members."},"3956.28":{"start":"3956.28","dur":"2.82","text":"So there&#39;s a little ways\nto go until we sort out"},"3959.10":{"start":"3959.1","dur":"1.27","text":"all those issues."},"3960.37":{"start":"3960.37","dur":"2.53","text":"AUDIENCE: When you\nidentified the mutations"},"3962.90":{"start":"3962.9","dur":"3.88","text":"and the responders,\ndo you also sequence"},"3966.78":{"start":"3966.78","dur":"1.646","text":"the genomes of the\npeople that don&#39;t"},"3968.43":{"start":"3968.426","dur":"2.249","text":"respond to confirm that they\ndon&#39;t have that mutation?"},"3970.68":{"start":"3970.675","dur":"2.416","text":"DAVID B. SOLIT: So for the\npaper we published in &quot;Science&quot;"},"3973.09":{"start":"3973.091","dur":"2.579","text":"on that Everolimus trial--\nI didn&#39;t show it here--"},"3975.67":{"start":"3975.67","dur":"1.506","text":"we unfortunately\ndidn&#39;t have tumor"},"3977.18":{"start":"3977.176","dur":"1.374","text":"for every patient\nfrom the study."},"3978.55":{"start":"3978.55","dur":"2.43","text":"But we did go back and\nsequence a host of patients"},"3980.98":{"start":"3980.98","dur":"1.18","text":"from the study."},"3982.16":{"start":"3982.16","dur":"1.9","text":"And what we found that\neven the patients who"},"3984.06":{"start":"3984.06","dur":"2.38","text":"had minor responses\nto Everolimus,"},"3986.44":{"start":"3986.44","dur":"1.81","text":"they also had a TSE1 mutation."},"3988.25":{"start":"3988.25","dur":"2.355","text":"But what we found is that\nthe co-mutation pattern"},"3990.61":{"start":"3990.605","dur":"1.375","text":"for those patients\nwas different."},"3991.98":{"start":"3991.98","dur":"2.44","text":"So this patient who had\nthe extraordinary response"},"3994.42":{"start":"3994.42","dur":"2.51","text":"had an NF2 mutation\nwith the TSE1."},"3996.93":{"start":"3996.93","dur":"2.08","text":"And both of those,\nwe think, cooperate"},"3999.01":{"start":"3999.01","dur":"1.86","text":"to make that patient\nexquisitely dependant"},"4000.87":{"start":"4000.87","dur":"1.8","text":"upon the target of that drug."},"4002.67":{"start":"4002.67","dur":"2.7","text":"Other patients had a TSE1\nmutation with other mutations"},"4005.37":{"start":"4005.37","dur":"2.83","text":"that we think diminish\naddiction to that target,"},"4008.20":{"start":"4008.2","dur":"2.24","text":"but maybe a combination\nwould be helpful."},"4010.44":{"start":"4010.44","dur":"2.532","text":"I think the learning experience\nfrom that was going back,"},"4012.97":{"start":"4012.972","dur":"1.958","text":"we realized we didn&#39;t\nhave tumor from everyone."},"4014.93":{"start":"4014.93","dur":"5.13","text":"So I think now we&#39;re trying to\ndo a much better job of making"},"4020.06":{"start":"4020.06","dur":"1.5","text":"sure that when we\nrun these studies,"},"4021.56":{"start":"4021.56","dur":"2.884","text":"we collect these tumors and\nhave the material available"},"4024.44":{"start":"4024.444","dur":"1.666","text":"for these type of\nretrospective studies."},"4026.11":{"start":"4026.11","dur":"2.347","text":"But actually some of the\nextraordinary responders"},"4028.46":{"start":"4028.457","dur":"1.833","text":"initiatives are not\ngoing to even be needed."},"4030.29":{"start":"4030.29","dur":"2.87","text":"Because if we have the\nmutation data perspectively,"},"4033.16":{"start":"4033.16","dur":"2.24","text":"it just becomes very\nobvious sometimes why"},"4035.40":{"start":"4035.4","dur":"0.95","text":"somebody responded."},"4036.35":{"start":"4036.35","dur":"1.416","text":"Well, they had the\nright mutation."},"4037.77":{"start":"4037.766","dur":"3.634","text":"And so the key is again getting\nthe tissue for study later on."},"4041.40":{"start":"4041.4","dur":"1.1","text":"And it&#39;s a challenge."},"4042.50":{"start":"4042.5","dur":"3.21","text":"I&#39;m actually minimizing how\nbig of a challenge it is."},"4045.71":{"start":"4045.71","dur":"3.08","text":"It&#39;s not necessarily just good\nenough to have a piece of tumor"},"4048.79":{"start":"4048.79","dur":"1.91","text":"from five years ago\nfrom the patient."},"4050.70":{"start":"4050.7","dur":"2.38","text":"If they&#39;ve had 10\ntherapies along the way,"},"4053.08":{"start":"4053.08","dur":"2.89","text":"the tumor may have changed\nsignificantly during that time"},"4055.97":{"start":"4055.97","dur":"3.87","text":"and it&#39;s beyond what we&#39;re able\nto do for every clinical trial,"},"4059.84":{"start":"4059.84","dur":"2.46","text":"to get a new piece of tumor\nfrom every patient right"},"4062.30":{"start":"4062.3","dur":"1.88","text":"before they go on the therapy."},"4064.18":{"start":"4064.18","dur":"2.5","text":"Because that&#39;s\ninvasive, it&#39;s costly."},"4066.68":{"start":"4066.68","dur":"4.09","text":"And so we work with what\nwe have the best we can,"},"4070.77":{"start":"4070.77","dur":"1.39","text":"and it&#39;s not always perfect."},"4072.16":{"start":"4072.16","dur":"1.82","text":"Well, thank you."},"4073.98":{"start":"4073.98","dur":"3.05","text":"[APPLAUSE]"}}